commit c92e9c5f9940abcb2c7950377e1c2245059cad90
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Mon Mar 1 10:54:09 2021 +0100

    MARCH 2021

diff --git a/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml b/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml
old mode 100755
new mode 100644
index 0f7c693..9d053b9
--- a/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml	
+++ b/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2021-02-01 04:28:07" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2021-03-01 04:28:15" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="10521">
+  <DisorderList count="10524">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166024</ExpertLink>
@@ -797,7 +797,11 @@
       <OrphaCode>166068</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166068</ExpertLink>
       <Name lang="en">Pontocerebellar hypoplasia type 5</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -813,7 +817,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
+      <ExternalReferenceList count="2">
         <ExternalReference id="139338">
           <Source>UMLS</Source>
           <Reference>C1857762</Reference>
@@ -825,19 +829,6 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="120425">
-          <Source>ICD-10</Source>
-          <Reference>Q04.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
         <ExternalReference id="38970">
           <Source>OMIM</Source>
           <Reference>610204</Reference>
@@ -850,9 +841,26 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="17608">
+            <OrphaCode>166063</OrphaCode>
+            <Name lang="en">Pontocerebellar hypoplasia type 4</Name>
+          </TargetDisorder>
+          <RootDisorder id="17609" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Pontocerebellar hypoplasia type 4</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8">
@@ -1031,7 +1039,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="17608" cycle="true"/>
+          <RootDisorder id="17609">
+            <OrphaCode>166068</OrphaCode>
+            <Name lang="en">Pontocerebellar hypoplasia type 5</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="73346" lang="en">
@@ -2483,17 +2501,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="178497">
+        <ExternalReference id="187716">
           <Source>ICD-10</Source>
-          <Reference>Q77.7</Reference>
+          <Reference>Q87.0</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -7385,8 +7403,8 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="2">
-        <ExternalReference id="120376">
+      <ExternalReferenceList count="1">
+        <ExternalReference id="187714">
           <Source>ICD-10</Source>
           <Reference>G04.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -7395,19 +7413,6 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="120375">
-          <Source>ICD-10</Source>
-          <Reference>G13.1</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
           <DisorderMappingValidationStatus id="21611">
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
@@ -8546,17 +8551,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="120378">
+        <ExternalReference id="187715">
           <Source>ICD-10</Source>
-          <Reference>A86</Reference>
+          <Reference>G04.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -11473,7 +11478,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Lafora disease (LD) is a rare, inherited, severe, progressive myoclonic epilepsy characterized by myoclonus and/or generalized seizures, visual hallucinations (partial occipital seizures), and progressive neurological decline.</Contents>
+              <Contents>A rare, inherited, severe, progressive myoclonic epilepsy characterized by myoclonus and/or generalized seizures, visual hallucinations (partial occipital seizures), and progressive neurological decline.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -12234,7 +12239,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Sickle cell anemias are chronic hemolytic diseases that may induce three types of acute accidents: severe anemia, severe bacterial infections, and ischemic vasoocclusive accidents (VOA) caused by sickle-shaped red blood cells obstructing small blood vessels and capillaries. Many diverse complications can occur.</Contents>
+              <Contents>A severe form of sickle cell disease (SCD) characterized by homozygosity for the sickle hemoglobin (HbS) gene and which acutely manifests with severe anemia, susceptibility to severe bacterial infections, and ischemic vasoocclusive accidents (VOA). It is a red cell disease of genetic origin which manifests with hemolytic disease and loss of red cell deformability leading to other occlusive events.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -13744,7 +13749,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Wilson disease is a very rare inherited multisystemic disease presenting non-specific neurological, hepatic, psychiatric or osseo-muscular manifestations due to excessive copper deposition in the body.</Contents>
+              <Contents>A rare inherited multisystemic disease presenting non-specific neurological, hepatic, psychiatric or osseo-muscular manifestations due to excessive copper deposition in the body.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -15364,7 +15369,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123536" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160917" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare non-acquired pituitary hormone deficiency characterized by growth deficiency, delayed bone age, and short stature of variable severity and age of onset, and with variable response to treatment with recombinant human growth hormone, depending on the respective subtype of the disease. Hormone deficiency may be quantitative or qualitative in nature.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="170">
@@ -16960,7 +16975,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Maffucci syndrome is a very rare genetic bone and skin disorder characterized by multiple enchondromas, leading to bone deformities, combined with multiple dark, irregularly shaped hemangiomas or less commonly lymphangiomas.</Contents>
+              <Contents>A rare nonhereditary mesodermal dysplasia characterized by multiple enchondromatosis associated with soft tissue hemangiomas.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -17266,7 +17281,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="120364">
+        <ExternalReference id="187713">
           <Source>ICD-10</Source>
           <Reference>G40.5</Reference>
           <DisorderMappingRelation id="21534">
@@ -17275,8 +17290,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -19817,7 +19832,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A hereditary disease that develops in adulthood and is characterized by chronic liver disorders (cirrhosis), respiratory disorders (emphysema), and rarely panniculitis.</Contents>
+              <Contents>A hereditary disease that develops in adulthood and is characterized by chronic liver disorders (cirrhosis), respiratory disorders (emphysema), and rarely panniculitis. Serum levels of alpha-1-antitrypsin (AAT), the main protease inhibitor (PI) in human serum, are low.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -21686,7 +21701,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare genetic disorder characterized by an unusual complex of congenital developmental abnormalities with intellectual disability, and an increased risk of developing Wilms tumor.</Contents>
+              <Contents>A rare genetic disorder characterized by the association of total or partial aniridia, genitourinary anomalies (ranging from sexual ambiguity to ectopia testis), variable degrees of intellectual disability, and an increased risk of developing Wilms tumor. Glaucoma or cataract are also possible, and a minority of patients develop kidney failure. Other varaible findings may include obesity and duplicated halluces.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -23448,7 +23463,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies is a group of clinically heterogeneous diseases, commonly defined by lack of cellular energy due to defects of oxidative phosphorylation (OXPHOS), resulting from pathogenic mutations in the nuclear DNA. Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies includes diseases classified according to defects in: genes encoding structural components of OXPHOS complexes (such as Leigh syndrome, coenzyme Q10 deficiency); genes encoding assembly factors of OXPHOS complexes (such as GRACILE syndrome); genes altering the stability of mitochondrial DNA (such as autosomal dominant progressive external ophthalmoplegia, mitochondrial DNA depletion syndrome); mitochondrial protein synthesis (see these terms).</Contents>
+              <Contents>A group of clinically heterogeneous diseases, commonly defined by lack of cellular energy due to defects of oxidative phosphorylation (OXPHOS), resulting from pathogenic mutations in the nuclear DNA. Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies includes diseases classified according to defects in: genes encoding structural components of OXPHOS complexes (such as Leigh syndrome, coenzyme Q10 deficiency); genes encoding assembly factors of OXPHOS complexes (such as GRACILE syndrome); genes altering the stability of mitochondrial DNA (such as autosomal dominant progressive external ophthalmoplegia, mitochondrial DNA depletion syndrome); mitochondrial protein synthesis.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -24067,7 +24082,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Meckel syndrome (MKS) is a rare, lethal, genetic, multiple congenital anomaly disorder characterized by the triad of brain malformation (mainly occipital encephalocele), large polycystic kidneys, and polydactyly, as well as associated abnormalities that may include cleft lip/palate, cardiac and genital anomalies, central nervous system (CNS) malformations, liver fibrosis, and bone dysplasia.</Contents>
+              <Contents>A rare, lethal, genetic, multiple congenital anomaly disorder characterized by the triad of brain malformation (mainly occipital encephalocele), large polycystic kidneys, and polydactyly, as well as associated abnormalities that may include cleft lip/palate, cardiac and genital anomalies, central nervous system (CNS) malformations, liver fibrosis, and bone dysplasia.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -24183,7 +24198,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Ellis-van Creveld syndrome (EVC) is a skeletal and ectoderlam dysplasia characterized by a tetrad of short stature, postaxial polydactyly, ectodermal dysplasia, and congenital heart defects.</Contents>
+              <Contents>A rare chondral and ectodermal dysplasia characterized by short ribs, polydactyly, growth retardation, and ectodermal and heart defects.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -28645,7 +28660,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Trisomy 18p is an extremely rare chromosomal anomaly with a poorly defined clinical phenotype. Reported manifestations include short stature, mild, moderate or severe developmental delay and intellectual disability, variable but mild facial dysmorphism, and epilepsy.</Contents>
+              <Contents>A rare partial trisomy of the short arm of chromosome 18 manifesting with a highly variable clinical phenotype which may include variable developmental delay and intellectual disability, epilepsy, and non-specific dysmorphic features, among others.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -31486,7 +31501,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome is characterised by multiple fractures in the prenatal period, microcephaly and bilateral cataracts. It has been described in three infants all of whom died &lt;i&gt;in utero&lt;/i&gt; or a few hours after birth. The mode of inheritance appears to be autosomal recessive.</Contents>
+              <Contents>A rare multiple congenital malformations/dysmorphic syndrome characterized by osteogenesis imperfecta with multiple prenatal bone fractures, joint laxity, severe microcephaly, and bilateral cataracts. Additional reported manifestations include dysmorphic facial features (such as blue sclerae, hypertelorism, and low-set ears), lissencephaly, hydrocephalus, and cardiac and genital anomalies. The syndrome is lethal &lt;i&gt;in utero&lt;/i&gt; or shortly after birth. There have been no further descriptions in the literature since 1978.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -35443,7 +35458,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Retinitis pigmentosa - intellectual disability - deafness - hypogenitalism is an extremely rare syndromic retinitis pigmentosa characterized by pigmentary retinopathy, diabetes mellitus with hyperinsulinism, acanthosis nigricans, secondary cataracts, neurogenic deafness, short stature mild hypogonadism in males and polycystic ovaries with oligomenorrhea in females. Inheritance is thought to be autosomal recessive. It can be distinguished from Alstrom syndrome (see this term) by the presence of intellectual disability and the absence of renal insufficiency. There have been no further descriptions in the literature since 1993.</Contents>
+              <Contents>A rare syndromic retinitis pigmentosa characterized by pigmentary retinopathy, diabetes mellitus with hyperinsulinism, acanthosis nigricans, secondary cataracts, neurogenic deafness, short stature mild hypogonadism in males and polycystic ovaries with oligomenorrhea in females. Inheritance is thought to be autosomal recessive. It can be distinguished from Alstrom syndrome (see this term) by the presence of intellectual disability and the absence of renal insufficiency. There have been no further descriptions in the literature since 1993.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -36444,7 +36459,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179636">
+        <ExternalReference id="187697">
           <Source>ICD-10</Source>
           <Reference>Q04.0</Reference>
           <DisorderMappingRelation id="21534">
@@ -36453,8 +36468,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -40053,7 +40068,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Gonadal dysgenesis with multiple anomalies is an association syndrome described only once in two sisters aged 1 1/2 and 8 1/2 years. They had a 46,XY karyotype, cleft lip and palate, preauricular pits, and a 'squashed down' appearance because of a short columella and small nares. Other anomalies included broad hands and feet, and a hypermuscular appearance. Cardiac, renal, musculoskeletal, and ectodermal anomalies were also present. Ectodermal defects included 'punched out scalp defects' and unusual positioning of hair whorls. They also had short stature, streak gonads, and mild developmental delay. The mode of inheritance is most likely autosomal recessive.</Contents>
+              <Contents>A rare syndrome with 46,XY disorder of sex development characterized by mild developmental delay and streak gonads associated with short stature, cardiac, renal, musculoskeletal, and ectodermal abnormalities (the latter including scalp defects and unusual hair whorls), and dysmorphic facial features (such as preauricular pits, short columella, and small nares). There have been no further descriptions in the literature since 1980.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -43693,7 +43708,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Ebstein's malformation is a rare congenital cardiac anomaly characterized by rotational displacement of the septal and inferior leaflets of the tricuspid valve such that they are hinged within the right ventricle, rather than as expected at the atrioventricular junction.</Contents>
+              <Contents>A rare congenital cardiac anomaly characterized by downward (apical) displacement of the functional annulus, due to incomplete delamination of the septal and inferior leaflets of the tricuspid valve such that they are hinged within the right ventricle, rather than as expected at the atrioventricular junction. The anterosuperior leaflet is often abnormal (redundancy, fenestrations, tethering with abnormal subvalvar apparatus). The atrioventricular junction and the ''atrialized'' portion of the right ventricle are dilated, with variable degrees of thinning of the right ventricular wall.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -47868,7 +47883,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A very rare, genetic, multiple congenital anomaly disorder characterized by bone abnormalities, distinctive facial features, multiple exostoses, and intellectual disability.</Contents>
+              <Contents>A rare multiple congenital anomalies syndrome characterized by the association of intellectual disability and numerous other anomalies including redundant skin, multiple cartilaginous exostoses, characteristic facies and cone-shaped phalangeal epiphyses.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -48609,17 +48624,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="178090">
+        <ExternalReference id="187718">
           <Source>ICD-10</Source>
           <Reference>D24</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -49025,7 +49040,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A very rare genetic multisystemic disorder characterized by pituitary dysfunction, ataxia, peripheral neuropathy, spastic paraplegia, and chorioretinal dystrophy.</Contents>
+              <Contents>A very rare genetic multisystemic disorder characterized by progressive neurological, ophthalmologic and endocrine manifestations leading to severe handicap.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -49563,7 +49578,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Muir-Torre syndrome (MTS) is a form of hereditary nonpolyposis colon cancer (HNPCC) characterized by cutaneous sebaceous tumors, keratoacanthomas and at least one visceral malignancy, most frequently gastrointestinal carcinoma.</Contents>
+              <Contents>A form of hereditary nonpolyposis colon cancer characterized by the development of cutaneous sebaceous neoplasia and at least one visceral malignancy, most frequently gastrointestinal carcinoma. The malignancies are usually multiple, occur at an early age, but tend to be of low-grade and have a relatively low incidence of metastases. Sebaceous tumors are usually multiple, with sebaceous adenomas being the commonest. Multiple keratoacanthomas, usually located on the face or the trunk, have been reported as a feature. Cutaneous tumors may precede or follow the first presentation of internal malignancy, which usually involves the gastrointestinal tract, the breast or the genitourinary tract.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -49697,7 +49712,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A very rare congenital cranial dysinnervation disorder characterized by complete or incomplete facial paralysis in association with bilateral palsy of the abducens nerve causing impairment of ocular abduction. The syndrome also includes various other congenital anomalies.</Contents>
+              <Contents>A very rare congenital cranial dysinnervation disorder characterized by unilateral or bilateral non progressive congenital facial palsy (VII cranial nerve) with impairments of ocular abduction (VI cranial nerve). It can also be associated with other cranial nerves palsies, orofacial anomalies and limb defects.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -57705,7 +57720,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.</Contents>
+              <Contents>A rare idiopathic inflammatory myopathy (IIM) characterized by evocative skin lesions, muscle involvement with symmetrical proximal muscle weakness, and specific histological features. The clinical subtypes are defined by the presence of myositis-specific antibodies (anti-Mi2, anti-NXP2, anti-TIF1-&amp;#947;, anti-MDA5, or anti-SAE antibodies) and are associated with specific clinical phenotypes and prognosis.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -57826,7 +57841,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="153085">
+        <ExternalReference id="187717">
           <Source>ICD-10</Source>
           <Reference>C84.5</Reference>
           <DisorderMappingRelation id="21534">
@@ -57835,8 +57850,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -58389,7 +58404,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Inclusion body myositis (IBM) is a slowly progressive degenerative inflammatory disorder of skeletal muscles characterized by late onset weakness of specific muscles and distinctive histopathological features.</Contents>
+              <Contents>A rare degenerative inflammatory disorder of skeletal muscles characterized by late onset weakness, starting in either the quadriceps or finger flexors and slowly progressing to include other groups of limb muscles. Distinctive histopathological features include inflammatory and degenerative features.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -60483,9 +60498,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="2">
+      <SynonymList count="1">
         <Synonym lang="en">EBS</Synonym>
-        <Synonym lang="en">EEB</Synonym>
       </SynonymList>
       <DisorderType id="21436">
         <Name lang="en">Clinical group</Name>
@@ -60519,7 +60533,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="1">
+      <DisorderDisorderAssociationList count="3">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="641" cycle="true"/>
+          <RootDisorder id="11904">
+            <OrphaCode>89839</OrphaCode>
+            <Name lang="en">OBSOLETE: Epidermolysis bullosa simplex superficialis</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
         <DisorderDisorderAssociation>
           <TargetDisorder id="641" cycle="true"/>
           <RootDisorder id="17230">
@@ -60530,6 +60554,16 @@
             <Name lang="en">Referred to</Name>
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="641" cycle="true"/>
+          <RootDisorder id="17231">
+            <OrphaCode>158665</OrphaCode>
+            <Name lang="en">OBSOLETE: Basal epidermolysis bullosa simplex</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="2784" lang="en">
@@ -70747,7 +70781,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123533" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160916" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare larynx anomaly characterized by complete absence of the laryngeal lumen resulting in congenital upper airway obstruction syndrome which, without fetal or neonatal intervention, is incompatible with life. Fetal sonography shows a dilated trachea, hyperechoic lungs, pleural effusion, minimal fetal abdominal ascites or hydrops, and amniotic fluid abnormalities.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="724">
@@ -71860,7 +71904,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Tricuspid atresia is (TA) a rare congenital heart malformation characterized by the congenital agenesis of tricuspid valve leading to severe hypoplasia of right ventricle (functionally univentricular). TA is associated with normally related or transposed great vessels (TGV, see this term), an obligatory interatrial connection that is crucial for survival (patent foramen ovale or atrial septal defect, osteum secondum type), ventricular septal defect (in 90% cases), pulmonary outflow obstruction - pulmonary atresia, stenosis or hypoplasia (usually in TA with normally related vessels but also in TGV), aortic coarctation and/or aortic arch interruption (usually in TA with TGV)(see these terms).</Contents>
+              <Contents>A rare congenital heart malformation characterized by absence of the tricuspid valuvar annulus (absent right atrioventricular connection/junction) or an imperforate tricuspid valve leading to severe hypoplasia of right ventricle (functionally univentricular heart). The malformation is associated with normally related great arteries (70 to 80% of cases) or transposed great vessels, an obligatory interatrial connection that is crucial for survival (patent oval foramen or atrial septal defect ostium secundum type), ventricular septal defect (VSD), pulmonary outflow obstruction (pulmonary atresia, stenosis or hypoplasia), aortic coarctation and/or aortic arch interruption.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -82565,18 +82609,70 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="5">
-        <ExternalReference id="179637">
+      <ExternalReferenceList count="9">
+        <ExternalReference id="187700">
           <Source>ICD-10</Source>
-          <Reference>A16.9</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <Reference>A17</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187699">
+          <Source>ICD-10</Source>
+          <Reference>A16</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187701">
+          <Source>ICD-10</Source>
+          <Reference>A18</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187702">
+          <Source>ICD-10</Source>
+          <Reference>A19</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187698">
+          <Source>ICD-10</Source>
+          <Reference>A15</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="107348">
@@ -85151,7 +85247,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Seckel syndrome is a type of microcephalic primordial dwarfism that is characterized by a proportionate dwarfism of prenatal onset, a severe microcephaly, a typical dysmorphic face (bird-like), and mild to severe intellectual disability.</Contents>
+              <Contents>A rare form of microcephalic primordial dwarfism characterized by a proportionate dwarfism of prenatal onset, a severe microcephaly, a typical dysmorphic face (bird-like), and mild to severe intellectual disability.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -105116,7 +105212,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A disorder characterised by the association of cerebral and cutaneous angiomatous lesions. It has been described in less than 10 families. Clinical manifestations of the cerebral lesions include epilepsy, cerebral haemorrhage, and focal neurological deficit. Transmission is autosomal dominant.</Contents>
+              <Contents>A rare genetic vascular anomaly characterized by the presence of angiomatous lesions affecting the skin, brain, and spinal cord. Lesions of the central nervous system have a marked tendency to bleed. There have been no further descriptions in the literature since 1988.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -105763,7 +105859,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Metaphyseal anadysplasia is a very rare form of metaphyseal dysplasia characterized by short stature, rhizomelic micromelia and a mild varus deformity of the legs evident from the first months of life, that is associated with radiological features of severe metaphyseal changes (irregularities, widening and marginal blurring) in long bones, most prominent in proximal femurs, and generalized osteopenia, and that usually spontaneously resolves by the age of three years. Severe autosomal dominant and milder recessive variants have been observed.</Contents>
+              <Contents>A rare form of metaphyseal dysplasia characterized by short stature, rhizomelic micromelia and a mild varus deformity of the legs evident from the first months of life, that is associated with radiological features of severe metaphyseal changes (irregularities, widening and marginal blurring) in long bones, most prominent in proximal femurs, and generalized osteopenia, and that usually spontaneously resolves by the age of three years. Severe autosomal dominant and milder recessive variants have been observed.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -109901,7 +109997,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="16890" cycle="true"/>
+          <RootDisorder id="16891">
+            <OrphaCode>139420</OrphaCode>
+            <Name lang="en">OBSOLETE: Secondary acute transverse myelitis</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="60433" lang="en">
@@ -110024,9 +110130,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=139420</ExpertLink>
       <Name lang="en">OBSOLETE: Secondary acute transverse myelitis</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="461">
-          <Value>1024</Value>
-          <Label>Obsolete with resources</Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
@@ -110040,7 +110146,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="16890">
+            <OrphaCode>139417</OrphaCode>
+            <Name lang="en">Acute transverse myelitis</Name>
+          </TargetDisorder>
+          <RootDisorder id="16891" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="0">
       </SummaryInformationList>
@@ -115057,7 +115173,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="171777">
+        <ExternalReference id="187712">
           <Source>ICD-10</Source>
           <Reference>P91.6</Reference>
           <DisorderMappingRelation id="21527">
@@ -115066,8 +115182,8 @@
           <DisorderMappingICDRelation id="21583">
             <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="138811">
@@ -121040,7 +121156,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare syndrome characterised by moderate to severe intellectual deficit, short stature, macrocephaly, and characteristic facies. It has been described in 11 males and three females from three successive generations of the same family. The males also presented with postpubertal macroorchidism. Transmission is X-linked.</Contents>
+              <Contents>A rare X-linked syndromic intellectual disability characterized by variable intellectual deficit, macrocephaly, short stature, and facial dysmorphism (such as prominent forehead, prominent supraorbital ridges, hypertelorism, downslanting palpebral fissures, broad nasal tip, anteverted nostrils, thick lower lip, and localized microdontia). Additional reported features include seizures, post-pubertal macroorchidism, obesity, and short, broad hands with tapered fingers.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -124209,7 +124325,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123537" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160918" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare lateral facial cleft characterized by a temporo-zygomatic defect, usually with absence of the zygomatic arch and deformities of the mandibular ramus, condyle, and coronoid process. Associated soft tissue abnormalities include malformations of the ear and hypoplasia or absence of the temporal muscle. Preauricular hair may be absent or divided into two portions. Facial manifestations include macrostomia (with extension of the cleft to the corner of the mouth) and pre-auricular tags. Incomplete clefts may be found in the molar region and between the maxillary tuberosity and pterygoid process.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17072">
@@ -124247,7 +124373,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123540" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160921" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare oblique facial cleft characterized by a defect between the maxilla and the zygomatic bone, opening into the infra-orbital fissure, accompanied by coloboma of the lower eyelid and a vertical furrow on the cheek oriented either laterally to the corner of the mouth or in the direction of the angle of the mandible. The posterior aspect of the maxilla is short with a high palate and choanal atresia. The malformation is typically associated with Treacher-Collins syndrome.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1649">
@@ -128608,7 +128744,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Carnosinemia is a very rare inherited disorder that presents with serum carnosinase deficiency.</Contents>
+              <Contents>A rare inborn error of metabolism characterized by low serum carnosinase activity, persistent carnosinuria, and carnosinemia. The clinical phenotype is highly variable, with some patients remaining asymptomatic, while others have been reported to show severe developmental delay, intellectual disability, hypotonia, seizures, and other neurological signs and symptoms.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -136717,7 +136853,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Dermatoosteolysis, Kirghizian type, is characterised by recurrent skin ulceration, arthralgia, fever, peri-articular osteolysis, oligodontia and nail dystrophy. This disease has been described in five sibs in a family of Kirghizian origin (Central Asia). Three of the sibs also presented with keratitis leading to visual impairment or blindess. Transmission is autosomal recessive.</Contents>
+              <Contents>A rare genetic disease characterized by infantile onset of recurrent skin ulcerations, arthralgias, fever, peri-articular fistulous osteolysis, oligodontia, nail dystrophy, and keratitis. The disease takes a self-limiting course in childhood but results in severe cicatrization, chronic arthroses, pseudoacromegalic appearance of hands and feet, secondary scoliosis, and visual impairment. There have been no further descriptions in the literature since 1983.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -142806,18 +142942,16 @@
     <Disorder id="1686">
       <OrphaCode>1519</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=1519</ExpertLink>
-      <Name lang="en">Hypertelorism, Teebi type</Name>
+      <Name lang="en">SPECC1L-related hypertelorism syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
+      <SynonymList count="2">
         <Synonym lang="en">Brachycephalofrontonasal dysplasia</Synonym>
-        <Synonym lang="en">Craniofrontonasal dysplasia, Teebi type</Synonym>
         <Synonym lang="en">Teebi hypertelorism syndrome</Synonym>
-        <Synonym lang="en">Teebi syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21401">
         <Name lang="en">Malformation syndrome</Name>
@@ -142955,7 +143089,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Craniofrontonasal dysplasia is an X-linked malformation syndrome characterized by facial asymmetry (particularly orbital), body asymmetry, midline defects (hypertelorism, frontal bossing, broad grooved or bifid nasal tip, cleft lip and/or palate, high arched palate), skeletal anomalies (clavicle pseudoarthrosis, coronal craniosynostosis, various digital and limb anomalies including syndactyly, clinodactyly of the 5th finger, broad thumbs) and ectodermal dysplasias (dental anomalies, grooved nails, wiry hair). Contrary to most X-linked disorders, females are much more severely affected whereas males are asymptomatic or present with a mild phenotype, frequently only displaying hypertelorism.</Contents>
+              <Contents>A rare X-linked malformation syndrome characterized by craniofacial abnormalities, grooved nails, intellectual disability and various skeletal and soft tissue abnormalities.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -143402,7 +143536,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Craniofacial dyssynostosis (CFD) is a rare cranial malformation syndrome characterized by the premature closure of both lambdoid sutures and the posterior sagittal suture, resulting in abnormal skull contour (frontal bossing, anterior turricephaly with mild brachycephaly, biparietal narrowing, occipital concavity) and dysmorphic facial features (low-set ears, midfacial hypoplasia). Short stature, developmental delay, epilepsy, and oculomotor dyspraxia have also been reported. Associated anomalies include enlargement of the cerebral ventricles, agenesis of the corpus callosum, Arnold-Chiari malformation type I (see this term), venous anomalies of skull and hydrocephalus.</Contents>
+              <Contents>A rare cranial malformation syndrome characterized by the premature closure of both lambdoid sutures and the posterior sagittal suture, resulting in abnormal skull contour (frontal bossing, anterior turricephaly with mild brachycephaly, biparietal narrowing, occipital concavity) and dysmorphic facial features (low-set ears, midfacial hypoplasia). Short stature, developmental delay, epilepsy, and oculomotor dyspraxia have also been reported. Associated anomalies include enlargement of the cerebral ventricles, agenesis of the corpus callosum, Arnold-Chiari malformation type I, venous anomalies of skull, and hydrocephalus.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -143723,7 +143857,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Craniofacial-deafness-hand syndrome (CDHS) is an autosomal dominant disorder, described in one family to date, characterized by characteristic facial features (flat facial profile with normal calvarium, hypertelorism, small downslanting palpebral fissures, hypoplastic nose with button tip and slitlike nares, small ''pursed'' mouth), profound sensorineural deafness, and ulnar deviations and contractures of the hand. CDHS is thought to be an allelic variant of Waardenburg syndrome (see this term) that can be distinguished from the latter by its imaging findings and distinct facial features.</Contents>
+              <Contents>A rare autosomal dominant, multiple congenital anomalies syndrome characterized by facial dysmorphism (flat facial profile with normal calvarium, hypertelorism, small downslanting palpebral fissures, hypoplastic nose with button tip and slitlike nares, and small, pursed mouth), profound sensorineural deafness, ulnar deviations and contractures of the hand. This disorder is allelic to Waardenburg syndrome, and distinguished by the imaging findings and distinct facial features.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -144179,7 +144313,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare disorder characterized by Dandy-Walker malformation, severe intellectual deficit, macrocephaly, brachytelephalangy, facial dysmorphism and severe myopia. Three cases have been described. Transmission appears to be autosomal recessive.</Contents>
+              <Contents>A rare multiple congenital anomalies/dysmorphic syndrome characterized by severe intellectual deficit, Dandy-Walker malformation, macrocephaly, severe myopia, brachytelephalangy with short and broad fingernails, and dysmorphic facial features (such as thick eyebrows, synophrys, epicanthal folds, low-set ears, short philtrum, and high-arched palate). Additional reported manifestations include seizures and skeletal and genital anomalies, among others. There have been no further descriptions in the literature since 1989.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -147559,7 +147693,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Bullous dystrophy, macular type is a genetic disorder characterised by formation of bullae without traumatic origin, alopecia, hyperpigmentation, acrocyanosis, short stature, microcephaly, intellectual deficit, tapering fingers and nail abnormalities. Two families (one of whom was Dutch and the other Italian) have been described up to now, in which only males were affected. Transmission is X-linked recessive. The bullous dystrophy locus has been mapped to Xq26.3 in the Italian family and to Xq27.3 in the Dutch family.</Contents>
+              <Contents>A rare X-linked syndromic intellectual disability characterized by intellectual deficit, microcephaly, short stature, and ectodermal anomalies (including alopecia, spontaneous formation of bullae without evident trauma, hyper- or hypopigmented maculae, acrocyanosis, and dystrophic nails) in male patients. Additional reported features are short, tapering fingers, ocular anomalies (such as corneal opacities and cataract), and hypogenitalism. There have been no further descriptions in the literature since 1995.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -148473,7 +148607,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123592" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161009" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic eye disease characterized by abnormal proliferation of retinal tissue resulting in the formation of retinal folds, thereby causing gliosis and, clinically, variable degrees of visual impairment. No clinical findings other than those associated with the eyes have been demonstrated.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1821">
@@ -151467,7 +151611,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123527" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160910" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic bone development disorder characterized by multiple congenital fractures, slender ribs and long bones, deficient ossification of the skull, and dysmorphic facial features reminiscent of Hallermann-Streiff syndrome (such as high forehead and triangular face with small jaw, deep-set eyes, beaked, narrow nose, downturned mouth, and posteriorly angulated ears). Bilateral microphthalmia, cataracts, and pulmonary hypoplasia have also been reported. The disease is fatal in the neonatal period. There have been no further descriptions in the literature since 1995.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2023">
@@ -158433,7 +158587,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
+        <Synonym lang="en">EBS with pyloric atresia</Synonym>
         <Synonym lang="en">EBS-PA</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -158638,7 +158793,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
+        <Synonym lang="en">EBS with circinate migratory erythema</Synonym>
         <Synonym lang="en">EBS-migr</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -158702,7 +158858,7 @@
     <Disorder id="17234">
       <OrphaCode>158676</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=158676</ExpertLink>
-      <Name lang="en">Dominant dystrophic epidermolysis bullosa, nails only</Name>
+      <Name lang="en">Localized dystrophic epidermolysis bullosa, nails only</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -158710,7 +158866,7 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
-        <Synonym lang="en">Nails-only DDEB</Synonym>
+        <Synonym lang="en">Localized DEB, nails only</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -158751,14 +158907,15 @@
     <Disorder id="17233">
       <OrphaCode>158673</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=158673</ExpertLink>
-      <Name lang="en">Acral dystrophic epidermolysis bullosa</Name>
+      <Name lang="en">Localized dystrophic epidermolysis bullosa, acral form</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Localized DEB, acral form</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -159061,7 +159218,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Sternal cleft (SC) is a rare idiopathic congenital thoracic malformation characterized by a sternal fusion defect, that can be complete or partial (either superior or inferior), that is usually asymptomatic in the neonatal period (apart from a paradoxical midline thoracic bulging) but that can lead to dyspnea, cough, frequent respiratory infections and increased risk of trauma-related injury to the heart, lungs and major vessels if left untreated.</Contents>
+              <Contents>A rare idiopathic congenital thoracic malformation characterized by a sternal fusion defect, that can be complete or partial (either superior or inferior), that is usually asymptomatic in the neonatal period (apart from a paradoxical midline thoracic bulging) but that can lead to dyspnea, cough, frequent respiratory infections and increased risk of trauma-related injury to the heart, lungs and major vessels if left untreated.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -159844,9 +160001,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=158665</ExpertLink>
       <Name lang="en">OBSOLETE: Basal epidermolysis bullosa simplex</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="461">
-          <Value>1024</Value>
-          <Label>Obsolete with resources</Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="0">
@@ -159859,7 +160016,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="641">
+            <OrphaCode>304</OrphaCode>
+            <Name lang="en">Epidermolysis bullosa simplex</Name>
+          </TargetDisorder>
+          <RootDisorder id="17231" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="-1" lang="en">
@@ -163551,7 +163718,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
+        <Synonym lang="en">EBS with anodontia/hypodontia</Synonym>
         <Synonym lang="en">Kallin syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21401">
@@ -164196,7 +164364,7 @@
     <Disorder id="2233">
       <OrphaCode>2407</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=2407</ExpertLink>
-      <Name lang="en">LOC syndrome</Name>
+      <Name lang="en">Laryngo-onycho-cutaneous syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -164204,9 +164372,9 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="4">
+        <Synonym lang="en">LOC syndrome</Synonym>
         <Synonym lang="en">LOGIC syndrome</Synonym>
         <Synonym lang="en">Laryngeal and ocular granulation tissue in children from the Indian subcontinent syndrome</Synonym>
-        <Synonym lang="en">Laryngo-onycho-cutaneous syndrome</Synonym>
         <Synonym lang="en">Shabbir syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -167448,7 +167616,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Enchondromatosis is a rare primary bone dysplasia disorder characterized by the development of multiple mainly unilateral or asymmetrically distributed enchondromas throughout the metaphyses of the long bones.</Contents>
+              <Contents>A rare primary bone dysplasia disorder characterized by the development of multiple mainly unilateral or asymmetrically distributed enchondromas throughout the metaphyses of the long bones.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -168846,17 +169014,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179646">
+        <ExternalReference id="187721">
           <Source>ICD-10</Source>
-          <Reference>G11.2</Reference>
+          <Reference>G31.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -168869,7 +169037,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Sporadic adult-onset ataxia of unknown etiology describes a group of non-hereditary degenerative ataxias characterized by a slowly progressive cerebellar syndrome (with ataxia of stance and gait, upper limb dysmetria and intention tremor, ataxic speech, and oculomotor abnormalities), presenting in adulthood (at around 50 years of age), that is not due to a known cause. Extracerebellar symptoms (e.g., decreased vibration sense and absent or decreased ankle reflexes), polyneuropathy and mild autonomic dysfunction may also be present. Mild cognitive impairment has also rarely been reported.</Contents>
+              <Contents>A rare non-hereditary degenerative ataxia disease characterized by a slowly progressive cerebellar syndrome (with ataxia of stance and gait, upper limb dysmetria and intention tremor, ataxic speech, and oculomotor abnormalities), presenting in adulthood (at around 50 years of age), that is not due to a known cause. Extracerebellar symptoms (e.g., decreased vibration sense and absent or decreased ankle reflexes), polyneuropathy and mild autonomic dysfunction may also be present. Mild cognitive impairment has also rarely been reported.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -169862,7 +170030,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>McKusick-Kaufman syndrome is a very rare, genetic developmental disorder presenting in the neonatal period characterized by genitourinary malformations, polydactyly, and more rarely, congenital heart disease or gastrointestinal malformations.</Contents>
+              <Contents>A rare, genetic multiple congenital anomalies syndrome characterized by genitourinary malformations (hydrometrocolpos in females and in males, glanular hypospadias and prominent scrotal raphe) , postaxial polydactyly that may affect only one or several limbs, and to a lesser extent cardiac defects. Hydrometrocolpos is due to either a congenital obstruction, imperforate hymen or vaginal atressia, and causes a palpable mass and possibly hydronephrosis. Other anomalies occasionally reported include choanal atresia, pituitary dysplasia, esophageal atresia and distal tracheoesophageal fistula, Hirschsprung disease, vertebral anomalies, and hydrops fetalis. The disorder is allelic with Bardet-Biedl, and as some phenotypic overlap has been observed, patients should be reevaluated in later childhood for retinistis pigmentosas and other signs of Bardet-Biedl syndrome.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -171055,7 +171223,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="124984">
+        <ExternalReference id="187723">
           <Source>ICD-10</Source>
           <Reference>C71.9</Reference>
           <DisorderMappingRelation id="21534">
@@ -171064,8 +171232,8 @@
           <DisorderMappingICDRelation id="21597">
             <Name lang="en">Index term (The ORPHA code is listed in the ICD10 Index)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -174491,7 +174659,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Familial hypertryptophanemia is characterized by intellectual deficit associated with behavioral problems: periodic mood swings, exaggerated affective responses and abnormal sexual behavior. Twelve cases have been reported so far. Congenital abnormalities in tryptophan metabolism appear to be responsible for the tryptophanemia and tryptophanuria.</Contents>
+              <Contents>A rare inborn error of metabolism characterized by congenital hypertryptophanemia and hyperserotonemia. Patients are typically asymptomatic, although developmental delay, intellectual disability, and behavioral abnormalities, among others, have been reported in association.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -177021,17 +177189,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179638">
+        <ExternalReference id="187703">
           <Source>ICD-10</Source>
-          <Reference>G60.8</Reference>
+          <Reference>G60.0</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="140403">
@@ -179316,7 +179484,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>X-linked recessive hypoparathyroidism (XLHPT) is a very rare cause of hypoparathyroidism. It has been reported in two multigeneration families from Missouri. Affected males suffer from true neonatal idiopathic hypoparathyroidism leading to severe hypocalcemia with undetectable parathyroid hormone levels and epilepsy. They are also sterile. Carrier females are normocalcemic and asymptomatic. XLHPT is caused by congenital parathyroid gland agenesis. The XLHPT locus has been mapped to chromosome Xq26-q27, in a 1.5 Mb interval flanked by markers F9 and DXS984. Neonatal onset and parathyroid agenesis found at autopsy in one of the patients suggest that the gene involved in XLHPT plays a role in parathyroid gland development.</Contents>
+              <Contents>A rare genetic hypoparathyroidism characterized by severe hypocalcemia, seizures, hyperphosphatemia, and undetectable parathyroid hormone levels, in the absence of parathyroid tissue. Complications include psychomotor and growth delay, delayed dentition, and cataracts.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -181041,7 +181209,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic, dermis elastic tissue disease characterised by generalized joint hypermobility often complicated by dislocation of major joints, particularly the shoulder but in some cases the kneecap. Congenital hip dislocation has also been frequently reported. The syndrome has been described in several families. It is transmitted as an autosomal dominant trait, with high penetrance.</Contents>
+              <Contents>A rare genetic disease characterized by generalized joint laxity leading to recurrent dislocation of major joints, such as the hip (often with congenital hip dislocation), shoulder, elbow, or patella. Patients often experience muscle and joint pain (sometimes with effusion) and may develop degenerative joint changes at a relatively early age. Skin abnormalities are absent.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -181222,7 +181390,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Long bone bowing is a congenital condition described by the presence of symmetric or asymmetric angular deformity and shortening of the long bones, particularly the femurs, tibiae and ulnae.</Contents>
+              <Contents>A rare primary bone dysplasia characterized by congenital symmetric or asymmetric shortness and bowing of long bones, resulting in shortness of limbs and limited extension at the knees and elbows. Additional reported features are ''beaten metal'' appearance of the skull, dolichomacrocephaly, ocular hypertelorism, and anterior beaking and bone-within-bone appearance of vertebrae. There have been no further descriptions in the literature since 1993.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -182037,15 +182205,17 @@
     <Disorder id="19640">
       <OrphaCode>251393</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=251393</ExpertLink>
-      <Name lang="en">Localized junctional epidermolysis bullosa, non-Herlitz type</Name>
+      <Name lang="en">Localized junctional epidermolysis bullosa</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="3">
         <Synonym lang="en">JEB-nH loc</Synonym>
+        <Synonym lang="en">Junctional epidermolysis bullosa, non-Herlitz localized type</Synonym>
+        <Synonym lang="en">Localized JEB</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -182892,7 +183062,18 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="121940">
+        <ExternalReference id="50926">
+          <Source>OMIM</Source>
+          <Reference>604391</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation/>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187722">
           <Source>ICD-10</Source>
           <Reference>G11.3</Reference>
           <DisorderMappingRelation id="21534">
@@ -182901,17 +183082,6 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="50926">
-          <Source>OMIM</Source>
-          <Reference>604391</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
           <DisorderMappingValidationStatus id="21611">
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
@@ -188977,7 +189147,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179640">
+        <ExternalReference id="187705">
           <Source>ICD-10</Source>
           <Reference>Q04.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -188986,8 +189156,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -189403,7 +189573,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Odontotrichomelic syndrome is characterised by malformations of all four extremities, hypoplastic nails, ear anomalies, hypotrichosis, abnormal dentition, hyperhidrosis and nasolacrimal duct obstruction. So far, it has been described in less than 10 patients. Transmission is autosomal recessive.</Contents>
+              <Contents>A rare genetic disease characterized by intellectual disability, growth delay, absence deformities of upper and lower limbs, hypotrichosis, hypoplastic nails, abnormal dentition, abnormal auricles, hypoplastic nipples, thyroid enlargement, and abnormalities of tyrosine and/or tryptophane metabolism. Hypogonadism and cleft lip have also been reported. No new cases have been confirmed since 1970.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -194253,7 +194423,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Osteoporosis-oculocutaneous hypopigmentation syndrome is characterised by osteoporosis and congenital oculocutaneous hypopigmentation. Three cases have been described in the literature. The mode of inheritance appears to be autosomal recessive.</Contents>
+              <Contents>A rare genetic disease characterized by congenital oculocutaneous hypopigmentation, visual impairment, generalized osteoporosis with skeletal anomalies such as short stature, short neck and trunk, kyphosis, scoliosis, and platyspondyly, and dysmorphic facial features (including long philtrum, small mouth, micrognathia, and prominent ears). Moderate joint hyperelasticity and muscular hypotrophy have also been reported.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -195202,12 +195372,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="123565" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160981" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A group of rare mitochondrial oxidative phosphorylation disorders due to mitochondrial DNA anomalies characterized by progressive, most commonly proximal, myopathy with variable degrees of weakness, exercise-induced muscle pain, and fatigue. Progressive external ophthalmoplegia is often observed. Additional features include neurological signs and symptoms (such as seizures, stroke-like episodes, or developmental delay), cardiomyopathy, involvement of liver, kidneys, and gastrointestinal tract, and diabetes. Lactic acidosis is frequently present, while recurrent rhabdomyolysis and myoglobinuria are rare. Muscle biopsy may reveal the presence of ragged-red fibers and a mosaic pattern of cytochrome c oxidase-negative fibers.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -203441,17 +203614,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="5">
-        <ExternalReference id="179639">
+        <ExternalReference id="187704">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>G11.1</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="110119">
@@ -206730,7 +206903,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123530" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160913" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare primary bone dysplasia characterized by severe mesomelic shortness particularly of the lower limbs with distinctive triangular or rhomboid-shaped tibiae and fibulae, accompanied by bony protuberances and skin dimples. Additional manifestations include radioulnar synostosis, dislocation of the radial head, abnormalities of the hands (such as oligosyndactyly or fusiform-shaped fingers) and feet (pes equinovarus, synostoses of tarsals/metatarsals and phalanges), and dysmorphic facial features.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="19882">
@@ -221183,7 +221366,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123634" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161067" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare central nervous system malformation characterized by herniation of meninges through a permanent defect in the skull. It is lined by arachnoid and contains cerebrospinal fluid, but no brain tissue. Signs and symptoms depend on the location of the lesion and are related to mass effect, skull deformities, or leaking of cerebrospinal fluid.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="20205">
@@ -222041,7 +222234,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Penoscrotal transposition (PST) is a rare congenital genital anomaly in which the scrotum is positioned superior and anterior to the penis. PST may present with a broad spectrum of anomalies ranging from simple shawl scrotum (doughnut scrotum) to very complex extreme transposition with craniofacial, central nervous system, cardiac, gastrointestinal, urological, and other genital (undescended testicles, hypospadias, chordee) malformations. Growth deficiency and intellectual disability may also be noticed (60% of cases).</Contents>
+              <Contents>A rare congenital genital anomaly in which the scrotum is positioned superior and anterior to the penis. PST may present with a broad spectrum of anomalies ranging from simple shawl scrotum (doughnut scrotum) to very complex extreme transposition with craniofacial, central nervous system, cardiac, gastrointestinal, urological, and other genital (undescended testicles, hypospadias, chordee) malformations. Growth deficiency and intellectual disability may also be noticed (60% of cases).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -222456,7 +222649,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179641">
+        <ExternalReference id="187706">
           <Source>ICD-10</Source>
           <Reference>Q68.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -222465,8 +222658,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="47190">
@@ -223533,7 +223726,18 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="122447">
+        <ExternalReference id="94944">
+          <Source>OMIM</Source>
+          <Reference>614470</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation/>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187724">
           <Source>ICD-10</Source>
           <Reference>D72.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -223542,17 +223746,6 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="94944">
-          <Source>OMIM</Source>
-          <Reference>614470</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
           <DisorderMappingValidationStatus id="21611">
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
@@ -224296,8 +224489,8 @@
         <Synonym lang="en">Del(21)(q22.13q22.2)</Synonym>
         <Synonym lang="en">Monosomy 21q22.13q22.2</Synonym>
       </SynonymList>
-      <DisorderType id="21450">
-        <Name lang="en">Clinical subtype</Name>
+      <DisorderType id="21443">
+        <Name lang="en">Etiological subtype</Name>
       </DisorderType>
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
@@ -225078,8 +225271,7 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
-        <Synonym lang="en">Cohen-Hayden syndrome</Synonym>
+      <SynonymList count="0">
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -225669,7 +225861,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>46,XX disorder of sex development-skeletal anomalies syndrome is characterised by primary amenorrhoea, ambiguous external genitalia, and bone abnormalities (hypoplasia of the mandibular condyles, hypoplasia of the maxilla, ulnar dislocation of the radial heads, &lt;i&gt;etc&lt;/i&gt;.). It has been described in two sisters born to consanguineous parents.</Contents>
+              <Contents>A rare disorder of sex development characterized by primary amenorrhea and ambiguous external genitalia (enlarged clitoris with marked fusion of the labioscrotal folds) in association with skeletal anomalies (such as hypoplasia of the mandibular condyles and the maxilla, and ulnar dislocation of the radial heads), in the presence of a 46,XX karyotype and regular ovaries, fallopian tubes, and uterus. There have been no further descriptions in the literature since 1972.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -226390,7 +226582,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Triphalangeal thumbs-brachyectrodactyly syndrome is characterised by triphalangeal thumbs and brachydactyly of the hands. It has been described in four families and in one isolated case. Ectrodactyly of the feet and, more rarely, ectrodactyly of the hands were also reported in some family members. Transmission is autosomal dominant.</Contents>
+              <Contents>A rare genetic syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy characterized by duplication anomalies such as triphalangeal thumbs, phalangeal duplication of other digits, and polydactyly, associated with highly variable combinations of ectrodactyly, brachydactyly, and syndactyly of hands and/or feet. Severe nail dysplasia or absence of nails is also observed.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -231853,7 +232045,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179648">
+        <ExternalReference id="187725">
           <Source>ICD-10</Source>
           <Reference>K76.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -231862,8 +232054,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -235394,7 +235586,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>XK aprosencephaly syndrome is a very rare syndromic type of cerebral malformation characterized by aprosencephaly (absence of telencephalon and diencephalon), oculo-facial anomalies (i.e. ocular hypotelorism or cyclopia, malformation/absence of nasal structures, cleft lip), preaxial limb defects (i.e. hypoplastic hands, absent halluces) and various other anomalies including ambiguous genitalia, imperforate anus, and vertebral anomalies. The syndrome is thought to have an autosomal recessive mode of inheritance.</Contents>
+              <Contents>A rare syndromic type of cerebral malformation characterized by aprosencephaly (absence of telencephalon and diencephalon), oculo-facial anomalies (i.e. ocular hypotelorism or cyclopia, malformation/absence of nasal structures, cleft lip), preaxial limb defects (i.e. hypoplastic hands, absent halluces) and various other anomalies including ambiguous genitalia, imperforate anus, and vertebral anomalies. The syndrome is thought to have an autosomal recessive mode of inheritance.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -243108,7 +243300,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179649">
+        <ExternalReference id="187726">
           <Source>ICD-10</Source>
           <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -243117,8 +243309,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -250845,7 +251037,7 @@
         <Synonym lang="en">CLPED1</Synonym>
         <Synonym lang="en">Cleft lip/palate-syndactyly-pili torti syndrome</Synonym>
         <Synonym lang="en">Syndactyly-ectodermal dysplasia-cleft/lip palate</Synonym>
-        <Synonym lang="en">Zlotogora-Zilberman-Tenenbaum syndrome</Synonym>
+        <Synonym lang="en">Zlotogora-Ogur syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21401">
         <Name lang="en">Malformation syndrome</Name>
@@ -254028,7 +254220,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Necrotizing autoimmune myopathy (NAM) is a rare form of idiopathic inflammatory myopathy characterized clinically by acute or subacute proximal muscle weakness, and histopathologically by myocyte necrosis and regeneration without significant inflammation.</Contents>
+              <Contents>A rare form of idiopathic inflammatory myopathy characterized by acute or subacute, severe, symmetrical, proximal muscle weakness usually associated with muscle-specific antibodies (anti-HMGCR or anti-SRP). Histopathological characteristics include myocyte necrosis and regeneration without significant inflammation, and C5b-9 deposition on non-necrotic myofibers.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -254546,17 +254738,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179642">
+        <ExternalReference id="187707">
           <Source>ICD-10</Source>
-          <Reference>G60.8</Reference>
+          <Reference>Q68.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="95412">
@@ -257617,7 +257809,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Okamoto syndrome is characterised by congenital hydronephrosis, intellectual deficit, growth retardation, cleft palate, generalised hypotonia and a characteristic face. Cardiac anomalies have also been reported. To date, 6 cases have been reported.</Contents>
+              <Contents>A rare multiple congenital anomalies/dysmorphic syndrome characterized by severe developmental delay and intellectual disability, generalized hypotonia, growth failure, hydronephrosis, cardiac anomalies, and dysmorphic craniofacial features (such as microcephaly, hypertrichosis, synophrys, long eyelashes, epicanthus, flat nasal bridge, short, upturned nose, long philtrum, low-set ears, open-mouth appearance, full lower lip, cleft palate, and webbed neck). Thin corpus callosum, tethered spinal cord, intestinal malrotation, anal stenosis, and uterus didelphys have also been reported.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -258368,7 +258560,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Multiple osteochondromas (MO) is characterised by development of two or more cartilage capped bony outgrowths (osteochondromas) of the long bones.</Contents>
+              <Contents>A primary bone disorder characterized by development of two or more cartilage capped bony outgrowths (osteochondromas) at the surface of the bones.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -261880,7 +262072,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome is a multiple congenital anomalies syndrome, reported in the offsprings of a consanguineous couple and characterized by multiple congenital skeletal (dolichocephaly, skull asymmetry, camptodactyly, clubfoot), muscular (muscle hypoplasia), ocular (anophthalmia, buphthalmos, retinal detachment, aniridia (see this term)) and cardiac (prolapse of tricuspid valves, mitral and tricuspid insufficiency) abnormalities. An autosomal recessive inheritance with variable expressivity was suspected. There have been no further descriptions in the literature since 1992.</Contents>
+              <Contents>A rare multiple congenital anomalies syndrome, reported in the offsprings of a consanguineous couple and characterized by multiple congenital skeletal (dolichocephaly, skull asymmetry, camptodactyly, clubfoot), muscular (muscle hypoplasia), ocular (anophthalmia, buphthalmos, retinal detachment, aniridia (see this term)) and cardiac (prolapse of tricuspid valves, mitral and tricuspid insufficiency) abnormalities. An autosomal recessive inheritance with variable expressivity was suspected. There have been no further descriptions in the literature since 1992.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -263229,7 +263421,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Mseleni joint disease (MJD) is a rare and crippling chondrodysplasia, reported mainly in the Maputaland region in northern Kwazulu Natal, South Africa, characterized by a bilateral and uniform arthropathy of the joints that primarily and most severely affects the hip but that can also affect many other joints (i.e. knees, ankles, wrists, shoulders, elbows), and that manifests with pain and stiffness that progressively limits joint movement, eventually compromising a patient's ability to walk. Severe short staure and brachydactyly have been reported in a few patients with MJD.</Contents>
+              <Contents>A rare and crippling chondrodysplasia, reported mainly in the Maputaland region in northern Kwazulu Natal, South Africa, characterized by a bilateral and uniform arthropathy of the joints that primarily and most severely affects the hip but that can also affect many other joints (i.e. knees, ankles, wrists, shoulders, elbows), and that manifests with pain and stiffness that progressively limits joint movement, eventually compromising a patient's ability to walk. Severe short staure and brachydactyly have been reported in a few patients with MJD.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -269104,7 +269296,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A very rare, benign, cutaneous, slow-growing, vascular tumor mostly developing in infancy or early childhood.</Contents>
+              <Contents>A rare vascular tumour that may be either congenital or acquired (appearing before the age of 5 years) with slow angiomatous proliferation.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -269877,12 +270069,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="123651" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161256" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A group of rare, genetic, motor neuron disease characterized by childhood or adult onset progressive, predominantly proximal, muscular weakness and wasting. Included diseases are Autosomal dominant adult-onset proximal spinal muscular atrophy, Lower motor neuron syndrome with late-adult onset, and Autosomal dominant childhood-onset proximal spinal muscular atrophy.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -271064,7 +271259,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A very rare, aggressive, vascular tumor manifesting in the neonatal period or in infancy as cutaneous vascular tumors to large infiltrative lesions.</Contents>
+              <Contents>A rare low-grade malignant cutaneous or visceral vascular tumour that may be associated with severe thrombopaenia with consumption coagulopathy (Kasabach-Merritt syndrome) in pediatric patients.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -275062,7 +275257,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Congenital pulmonary stenosis (PS) is a congenital heart malformation (see this term) that is characterized by a right ventricular outflow obstruction with a clinical presentation that may vary from critical stenosis presenting in the neonatal period to asymptomatic mild stenosis. The obstruction in PS can be at the valvular, subpulmonary, or supravalvular levels (valvular, subpulmonary, supravalvular PS; see these terms).</Contents>
+              <Contents>A rare congenital heart malformation characterized by an obstruction to flow through the pulmonary valve with a clinical presentation that may vary from critical stenosis presenting in the neonatal period to asymptomatic mild stenosis. The obstruction at the valvular level can be associated with obstruction at the subpulmonary, or supravalvar levels (valvar, subpulmonary, supravalvar pulmonary stenosis (PS).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -275356,17 +275551,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="153082">
+        <ExternalReference id="187719">
           <Source>ICD-10</Source>
-          <Reference>C54.9</Reference>
+          <Reference>C54.1</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -277054,11 +277249,12 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="5">
+      <SynonymList count="6">
         <Synonym lang="en">Adducted thumb-clubfoot syndrome</Synonym>
         <Synonym lang="en">Distal arthrogryposis with peculiar facies and hydronephrosis</Synonym>
         <Synonym lang="en">Dndar syndrome</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome, Kosho type</Synonym>
+        <Synonym lang="en">Musculocontractural EDS</Synonym>
         <Synonym lang="en">mcEDS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -278420,7 +278616,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Double uterus, hemivagina and renal agenesis is a rare congenital urogenital anomaly characterized by the presence of double uterus (didelphys, bicornuate or septum-complete or partial), unilateral cervico-vaginal obstruction (obstructed hemivagina-communicant, not communicant or septate and unilateral cervical atresia) and ipsilateral renal anomalies (renal agenesis (see this term) and/or other urinary tract anomalies). Patients are usually diagnosed at puberty after menarche due to recurrent severe dysmenorrhea, chronic pelvic pain, excessive foul smelling mucopurulent discharge, spotting and intermenstrual bleeding (depending on the existence of uterine or vaginal communications). Fever, dyspareunia, and a palpable abdominal, pelvic or vaginal mass (mucocolpos or pyocolpos) may also be present.</Contents>
+              <Contents>A rare congenital urogenital anomaly characterized by the presence of double uterus (didelphys, bicornuate or septum-complete or partial), unilateral cervico-vaginal obstruction (obstructed hemivagina-communicant, not communicant or septate and unilateral cervical atresia) and ipsilateral renal anomalies (renal agenesis and/or other urinary tract anomalies). Patients are usually diagnosed at puberty after menarche due to recurrent severe dysmenorrhea, chronic pelvic pain, excessive foul smelling mucopurulent discharge, spotting and intermenstrual bleeding (depending on the existence of uterine or vaginal communications). Fever, dyspareunia, and a palpable abdominal, pelvic or vaginal mass (mucocolpos or pyocolpos) may also be present.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -279042,7 +279238,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Osteogenesis imperfecta type III is a severe type of osteogenesis imperfecta (OI; see this term), a genetic disorder characterized by increased bone fragility, low bone mass and susceptibility to bone fractures. The main signs of type III include very short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfecta (DI; see this term).</Contents>
+              <Contents>A severe type form osteogenesis imperfecta characterized by increased bone fragility and low bone mass clinically manifesting as susceptibility to bone fractures, short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfect.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -279270,7 +279466,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Osteogenesis imperfecta type IV is a moderate type of osteogenesis imperfecta (OI; see this term), a genetic disorder characterized by increased bone fragility, low bone mass and susceptibility to bone fractures. Patients with type IV have moderately short stature, mild to moderate scoliosis, grayish or white sclera, and dentinogenesis imperfecta (DI; see this term).</Contents>
+              <Contents>A moderate form of osteogenesis imperfecta characterized by increased bone fragility and low bone mass that clinically manifests as susceptibility to bone fractures, short stature, mild to moderate scoliosis, grayish or white sclera, and dentinogenesis imperfect.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -279363,7 +279559,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Osteogenesis imperfecta type V is a moderate type of osteogenesis imperfecta (OI; see this term), a genetic disorder characterized by increased bone fragility, low bone mass and susceptibility to bone fractures with variable severity. OI type V is characterized by mild to moderate short stature, dislocation of the radial head, mineralized interosseous membranes, hyperplasic callus, white sclera and no dentinogenesis imperfecta (DI; see this term).</Contents>
+              <Contents>A moderate form of osteogenesis imperfecta characterized by increased bone fragility and low bone mass that clinically manifests with susceptibility to bone fractures of variable severity, short stature, dislocation of the radial head, mineralized interosseous membranes, hyperplasic callus, white sclera and absence of dentinogenesis imperfect.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -280221,7 +280417,7 @@
         <DisorderDisorderAssociation>
           <TargetDisorder id="19201">
             <OrphaCode>231568</OrphaCode>
-            <Name lang="en">Generalized dominant dystrophic epidermolysis bullosa</Name>
+            <Name lang="en">Autosomal dominant generalized dystrophic epidermolysis bullosa</Name>
           </TargetDisorder>
           <RootDisorder id="18806" cycle="true"/>
           <DisorderDisorderAssociationType id="21471">
@@ -282309,18 +282505,20 @@
     <Disorder id="3423">
       <OrphaCode>2745</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=2745</ExpertLink>
-      <Name lang="en">Opitz G/BBB syndrome</Name>
+      <Name lang="en">Opitz GBBB syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="5">
+      <SynonymList count="7">
+        <Synonym lang="en">Hypertelorism-hypospadias syndrome</Synonym>
         <Synonym lang="en">Hypertelorism-oesophageal abnormality-hypospadias syndrome</Synonym>
         <Synonym lang="en">Hypospadias-dysphagia syndrome</Synonym>
-        <Synonym lang="en">Hypospadias-hypertelorism syndrome</Synonym>
-        <Synonym lang="en">Opitz syndrome</Synonym>
+        <Synonym lang="en">Opitz BBB/G syndrome</Synonym>
+        <Synonym lang="en">Opitz BBBG syndrome</Synonym>
+        <Synonym lang="en">Opitz G/BBB syndrome</Synonym>
         <Synonym lang="en">Opitz-Frias syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21401">
@@ -282388,7 +282586,27 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="2">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="3423" cycle="true"/>
+          <RootDisorder id="21237">
+            <OrphaCode>306588</OrphaCode>
+            <Name lang="en">OBSOLETE: Autosomal dominant Opitz G/BBB syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="3423" cycle="true"/>
+          <RootDisorder id="21238">
+            <OrphaCode>306597</OrphaCode>
+            <Name lang="en">OBSOLETE: X-linked Opitz G/BBB syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="12150" lang="en">
@@ -283454,17 +283672,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179643">
+        <ExternalReference id="187708">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>G11.1</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="7363">
@@ -283803,7 +284021,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123620" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161053" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic interstitial lung disease characterized by progressive, life-threatening, refractory respiratory distress in full-term neonates associated with surfactant protein B deficiency. In most cases, the disease is fatal within the first months of life. Lung biopsy reveals changes characteristic of pulmonary alveolar proteinosis with interstitial fibrosis and inflammation, as well as accumulation of lipid-rich, eosinophilic, proteinaceous, granular material consisting of desquamated type II pneumocytes and foamy macrophages within the alveolar air spaces.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="3439">
@@ -284517,17 +284745,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="121474">
+        <ExternalReference id="187720">
           <Source>ICD-10</Source>
-          <Reference>G90.8</Reference>
+          <Reference>G60.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -293639,29 +293867,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="2">
-        <ExternalReference id="69442">
-          <Source>OMIM</Source>
-          <Reference>610042</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="69443">
-          <Source>OMIM</Source>
-          <Reference>614325</Reference>
-          <DisorderMappingRelation id="21541">
-            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -302040,7 +302246,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123526" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160909" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare acquired dermis elastic tissue disorder characterized by clinical and histopathologic evidence of pseudoxanthoma elasticum in the absence of a family history or specific mutation. Patients present with predominantly cutaneous manifestations consisting of yellowish papules which coalesce into large plaques and are most commonly localized on the neck, axillae, groin, and flexural surfaces. Skin biopsy shows accumulation of clumped, calcified elastic fibers in the mid-dermis. Reported underlying factors include previous liver transplantation, exposure to penicillamine, or concomitant beta-thalassemia.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="19091">
@@ -305584,7 +305800,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123644" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161156" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare renal or urinary tract malformation characterized by ectatic precalyceal papillary collecting ducts, typically involving all renal papillae of both kidneys, and associated with impaired proximal and distal tubular function. Patients may be asymptomatic or present in young adulthood with recurrent stone formation, nephrocalcinosis, micro- and macrohematuria, recurrent urinary tract infection and pyelonephritis, hypercalciuria and hypocitraturia, and reduction in bone mineral density.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="19177">
@@ -305773,7 +305999,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare renal disease characterized by excess urinary calcium excretion in the absence of an underlying systemic disease. The condition leads to an increased risk for the formation of kidney stones and nephrocalcinosis, as well as reduced bone mineral density with increased incidence of fractures.</Contents>
+              <Contents>A rare renal disease characterized by persistent excess urinary calcium excretion in the absence of an underlying systemic disease and hypercalcemia. The condition leads to an increased risk for the formation of kidney stones and nephrocalcinosis, as well as reduced bone mineral density with increased incidence of fractures in some patients.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -309708,7 +309934,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Late-onset localized JEB-intellectual disability syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -309771,18 +309998,15 @@
     <Disorder id="19201">
       <OrphaCode>231568</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=231568</ExpertLink>
-      <Name lang="en">Generalized dominant dystrophic epidermolysis bullosa</Name>
+      <Name lang="en">Autosomal dominant generalized dystrophic epidermolysis bullosa</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
-        <Synonym lang="en">Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types</Synonym>
-        <Synonym lang="en">DDEB, Pasini and Cockayne-Touraine types</Synonym>
-        <Synonym lang="en">DDEB, generalized</Synonym>
-        <Synonym lang="en">DDEB-gen</Synonym>
+      <SynonymList count="1">
+        <Synonym lang="en">Generalized DDEB</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -310168,11 +310392,12 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="5">
+      <SynonymList count="6">
         <Synonym lang="en">Arterial-ecchymotic EDS</Synonym>
         <Synonym lang="en">EDS IV</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome type 4</Synonym>
         <Synonym lang="en">Sack-Barabas syndrome</Synonym>
+        <Synonym lang="en">Vascular EDS</Synonym>
         <Synonym lang="en">vEDS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -310338,11 +310563,12 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="5">
+      <SynonymList count="6">
         <Synonym lang="en">EDS III</Synonym>
         <Synonym lang="en">EDS-HT</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome hypermobility type</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome type 3</Synonym>
+        <Synonym lang="en">Hypermobile EDS</Synonym>
         <Synonym lang="en">hEDS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -310560,7 +310786,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="2">
+      <SynonymList count="3">
+        <Synonym lang="en">EBS with muscular dystrophy</Synonym>
         <Synonym lang="en">EBS-MD</Synonym>
         <Synonym lang="en">Limb-girdle muscular dystrophy with epidermolysis bullosa simplex</Synonym>
       </SynonymList>
@@ -310632,7 +310859,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="3">
+      <SynonymList count="4">
+        <Synonym lang="en">Dermatosparaxis EDS</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome type 7C</Synonym>
         <Synonym lang="en">Human dermatosparaxis EDS VIIC</Synonym>
         <Synonym lang="en">dEDS</Synonym>
@@ -310827,7 +311055,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="5">
+      <SynonymList count="6">
+        <Synonym lang="en">Arthrochalasia EDS</Synonym>
         <Synonym lang="en">Arthrochalasis multiplex congenita</Synonym>
         <Synonym lang="en">EDS VII</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome type 7</Synonym>
@@ -315441,7 +315670,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123636" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161069" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare beta-thalassemia associated with another hemoglobin anomaly characterized by the presence of the hemoglobin Lepore variant in association with beta-thalassemia. Clinical presentation is highly variable, depending on the type of beta-thalassemia, and ranges from severe hypochromic microcytic anemia and complete transfusion dependency to moderate, compensated anemia without a need for regular blood transfusions.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21963">
@@ -329669,12 +329908,15 @@
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="123528" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160911" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A group of rare renal tubular diseases characterized by primary defects in bicarbonate reabsorption from urine (proximal renal tubular acidosis) and/or hydrogen excretion into the lumen (distal renal tubular acidosis), resulting in metabolic acidosis with hyperchloremia and a normal plasma anion gap. The glomerular filtration rate is relatively normal.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -338018,20 +338260,7 @@
       <DisorderGroup id="36540">
         <Name lang="en">Group of disorders</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123904">
-          <Source>ICD-10</Source>
-          <Reference>Q93.2</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -345354,20 +345583,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123000">
-          <Source>ICD-10</Source>
-          <Reference>Q74.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -345892,17 +346108,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179650">
+        <ExternalReference id="187727">
           <Source>ICD-10</Source>
-          <Reference>G40.4</Reference>
+          <Reference>G96.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="61792">
@@ -346672,7 +346888,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>3MC syndrome describes a rare developmental disorder, that unifies the overlapping autosomal recessive disorders previously known as Carnevale, Mingarelli, Malpuech and Michels syndromes, characterized by a spectrum of developmental anomalies that include distinctive facial dysmorphism (i.e. hypertelorism, blepharophimosis, blepharoptosis, highly arched eyebrows), cleft lip and/or palate, craniosynostosis, learning disability, radioulnar synostosis and genital and vesicorenal anomalies. Less common features reported include anterior chamber defects, cardiac anomalies (e.g. ventricular septal defect; see this term), caudal appendage, umbilical hernia/omphalocele and diastasis recti.</Contents>
+              <Contents>A rare multiple congenital anomalies syndrome characterized by a spectrum of developmental anomalies including cleft lip and/or palate, craniosynostosis, learning disability, radioulnar synostosis, genital and vesicorenal anomalies. Observed facial dysmorphism includes hypertelorism, blepharophimosis, blepharoptosis, and high arched eyebrows. Less common features reported include anterior chamber defects, cardiac anomalies (e.g. ventricular septal defect), caudal appendage, umbilical hernia/omphalocele and diastasis recti.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -360677,17 +360893,16 @@
     <Disorder id="20589">
       <OrphaCode>284264</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=284264</ExpertLink>
-      <Name lang="en">IgG4-related disease</Name>
+      <Name lang="en">IgG4-related diseases</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="3">
-        <Synonym lang="en">IgG4-related sclerosing disease</Synonym>
-        <Synonym lang="en">IgG4-related systemic disease</Synonym>
-        <Synonym lang="en">Immunoglobulin G4-related sclerosing disease</Synonym>
+      <SynonymList count="2">
+        <Synonym lang="en">IgG4-related sclerosing diseases</Synonym>
+        <Synonym lang="en">Immunoglobulin G4-related sclerosing diseases</Synonym>
       </SynonymList>
       <DisorderType id="21436">
         <Name lang="en">Clinical group</Name>
@@ -361197,7 +361412,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Reversible cerebral vasoconstriction syndrome (RCVS) is an infrequent cerebrovascular disorder characterized by severe headaches with or without focal neurological deficits or seizures, and a reversible segmental and multifocal vasoconstriction of cerebral arteries.</Contents>
+              <Contents>A rare cerebrovascular disorder characterized by severe headaches with or without focal neurological deficits or seizures, and a reversible segmental and multifocal vasoconstriction of cerebral arteries. It may occur spontaneously or be provoked by various precipitating factors, the most common being postpartum and exposure to various vasoactive substances such as illicit drugs and selective serotonin-reuptake inhibitors. The major complication is ischemic or hemorrhagic stroke.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -363611,11 +363826,11 @@
       </DisorderFlagList>
       <SynonymList count="0">
       </SynonymList>
-      <DisorderType id="21394">
-        <Name lang="en">Disease</Name>
+      <DisorderType id="21450">
+        <Name lang="en">Clinical subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="en">Disorder</Name>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
         <ExternalReference id="98695">
@@ -363659,11 +363874,11 @@
         <Synonym lang="en">Del(12)(p12.1)</Synonym>
         <Synonym lang="en">Monosomy 12p12.1</Synonym>
       </SynonymList>
-      <DisorderType id="21401">
-        <Name lang="en">Malformation syndrome</Name>
+      <DisorderType id="21450">
+        <Name lang="en">Clinical subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="en">Disorder</Name>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
         <ExternalReference id="123514">
@@ -365315,17 +365530,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179651">
+        <ExternalReference id="187729">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>G11.2</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="74934">
@@ -374663,21 +374878,17 @@
     <Disorder id="21219">
       <OrphaCode>306504</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306504</ExpertLink>
-      <Name lang="en">Junctional epidermolysis bullosa with respiratory and renal involvement</Name>
+      <Name lang="en">Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="7">
-        <Synonym lang="en">Congenital ILNEB syndrome</Synonym>
-        <Synonym lang="en">Congenital NEP syndrome</Synonym>
-        <Synonym lang="en">Congenital interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome</Synonym>
-        <Synonym lang="en">Congenital nephrotic syndrome-epidermolysis bullosa-pulmonary disease syndrome</Synonym>
-        <Synonym lang="en">Congenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndrome</Synonym>
-        <Synonym lang="en">JEB with respiratory and renal involvement</Synonym>
-        <Synonym lang="en">JEB-RR</Synonym>
+      <SynonymList count="3">
+        <Synonym lang="en">ILNEB syndrome</Synonym>
+        <Synonym lang="en">JEB with interstitial lung disease and nephrotic syndrome</Synonym>
+        <Synonym lang="en">Junctional epidermolysis bullosa with interstitial lung disease and nephrotic syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -375191,11 +375402,11 @@
     <Disorder id="21238">
       <OrphaCode>306597</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306597</ExpertLink>
-      <Name lang="en">X-linked Opitz G/BBB syndrome</Name>
+      <Name lang="en">OBSOLETE: X-linked Opitz G/BBB syndrome</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
@@ -375209,63 +375420,31 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
-        <ExternalReference id="140146">
-          <Source>UMLS</Source>
-          <Reference>C2936904</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="123287">
-          <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="71929">
-          <Source>OMIM</Source>
-          <Reference>300000</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="3423">
+            <OrphaCode>2745</OrphaCode>
+            <Name lang="en">Opitz GBBB syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="21238" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This disease is described under  Opitz G/BBB syndrome</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21237">
       <OrphaCode>306588</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306588</ExpertLink>
-      <Name lang="en">Autosomal dominant Opitz G/BBB syndrome</Name>
+      <Name lang="en">OBSOLETE: Autosomal dominant Opitz G/BBB syndrome</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
@@ -375279,42 +375458,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="2">
-        <ExternalReference id="123286">
-          <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="71927">
-          <Source>OMIM</Source>
-          <Reference>145410</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="3423">
+            <OrphaCode>2745</OrphaCode>
+            <Name lang="en">Opitz GBBB syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="21237" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This disease is described under  Opitz G/BBB syndrome</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21236">
@@ -378772,7 +378930,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="153086">
+        <ExternalReference id="187728">
           <Source>ICD-10</Source>
           <Reference>D72.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -378781,8 +378939,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -379429,15 +379587,17 @@
     <Disorder id="21112">
       <OrphaCode>300333</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=300333</ExpertLink>
-      <Name lang="en">Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome</Name>
+      <Name lang="en">Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
-        <Synonym lang="en">Nephrotic syndrome-hearing loss-pretibial epidermolysis bullosa syndrome</Synonym>
+      <SynonymList count="3">
+        <Synonym lang="en">EBS with nephropathy</Synonym>
+        <Synonym lang="en">Epidermolysis bullosa simplex with nephropathy</Synonym>
+        <Synonym lang="en">Nephrotic syndrome-hearing loss-epidermolysis bullosa syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -380179,8 +380339,8 @@
       <SynonymList count="1">
         <Synonym lang="en">DYRK1A-related intellectual disability syndrome due to a point mutation</Synonym>
       </SynonymList>
-      <DisorderType id="21450">
-        <Name lang="en">Clinical subtype</Name>
+      <DisorderType id="21443">
+        <Name lang="en">Etiological subtype</Name>
       </DisorderType>
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
@@ -380189,7 +380349,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease is described under  DYRK1A-related intellectual disability syndrome</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="24023">
@@ -382638,7 +382805,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123562" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160969" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic disease characterized by a variable clinical phenotype which includes similar features but is typically less severe than in affected males. Patients may present with mild to borderline intellectual disability, anxiety, social phobia, selective mutism, attention deficit hyperactivity disorder, language deficit, neurologic signs and symptoms (such as seizures, hypotonia, and clonus), ophthalmologic anomalies (strabismus, refractive errors), and facial dysmorphism (including long face, prominent forehead, large, prominent ears, and mandibular prognathism).</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23619">
@@ -383141,7 +383318,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123531" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160914" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare hereditary palmoplantar keratoderma characterized by focal hyperkeratotic lesions on the palms and soles. Histopathologic examination reveals prominent hyperkeratosis, thickened stratum spinosum with reduced stratum granulosum, disadhesion of cells in the suprabasal layers, elongation of rete ridges, and sparse lymphocyte infiltration in the dermis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23564">
@@ -387708,7 +387895,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Idiopathic chronic eosinophilic pneumonia (ICEP) is a very rare, severe, interstitial lung disease of insidious onset with subacute or chronic non-specific respiratory manifestations (dyspnea, cough, wheezing) often associated with systemic manifestations (fatigue, malaise, weight loss).</Contents>
+              <Contents>A rare, severe, interstitial lung disease characterized by insidious onset with subacute or chronic non-specific respiratory manifestations (dyspnea, cough, wheezing) often associated with systemic manifestations (fatigue, malaise, weight loss) and a history of asthma (up to half of patients). Eosinophilia is present in most cases, usually in excess of 1000 cells/mm3.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -391126,7 +391313,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123563" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160970" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare mitochondrial disease characterized by failure to thrive, infantile encephalopathy, muscular hypotonia, global developmental delay and regression, pulmonary arterial hypertension, episodes of apnea and bradycardia, respiratory failure, hyperglycinemia, and lactic acidosis. Hypertrophic or dilated cardiomyopathy have also been reported. Brain imaging may show leukoencephalopathy involving variable regions. The disease is typically fatal in early infancy.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="22846">
@@ -391177,7 +391374,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123564" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160971" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare mitochondrial disease characterized by infantile onset of severe regression after a period of normal development, epileptic encephalopathy, hypotonia, movement disorder, cardiomyopathy, hyperglycinemia, and lactic acidosis. Optic atrophy may also be present. Brain imaging findings are highly variable and include white matter abnormalities. The disease is typically fatal in infancy.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="22840">
@@ -406149,7 +406356,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123497" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160719" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by profound intellectual disability, hypotonia, coarse facial features, strabismus and impaired visual fixation, hypermobility of interphalangeal joints, contractures in the elbow joints, and pes planovalgus. Seizures and episodes of aggressive behavior during sleep have also been reported.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23327">
@@ -408774,7 +408991,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123621" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161054" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare neuro-ophthalmological disease characterized by dysfunction of the ipsilateral lateral rectus muscle with esotropia in primary position, limited or no abduction of the eyeball, and compensatory horizontal face turn toward the palsied eye. The condition commonly resolves spontaneously.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23393">
@@ -410145,7 +410372,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Hemicrania continua is a rare, indomethacin-responsive, trigeminal autonomic cephalgia characterized by a typically side-locked, continuous, unilateral headache of moderate intensity with recurrent episodes of exacerbations of severe intensity, lasting for more than 3 months, in the absence of structural brain or vascular lesions. Ipsilateral cranial autonomic symptoms (lacrimation, conjunctival injection, nasal congestion or rhinorrhea, ptosis/miosis), restlessness and/or migrainous features are observed during the exacerbations.</Contents>
+              <Contents>A rare trigeminal autonomic cephalalgia characterized by indomethacin-sensitive, persistent, strictly unilateral headache lasting for more than three months, associated with ipsilateral conjunctival injection, lacrimation, nasal congestion, rhinorrhea, forehead and facial sweating, miosis, ptosis, eyelid edema, and/or restlessness or agitation, and not better accounted for by another type of headache. Migrainous symptoms such as photophobia are often observed. The headache may be continuous (unremitting subtype) or interrupted by remission periods of more than 24 hours (remitting subtype).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -413780,7 +414007,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123529" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160912" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic lethal multiple congenital anomalies/dysmorphic syndrome characterized by mid-gestation lethality and features of a ciliopathy. Clinical manifestations include hydrocephalus, cerebellar vermis hypoplasia, corpus callosum agenesis, duodenal atresia, gastrointestinal malrotation, bilateral renal hypoplasia, and dysmorphic craniofacial features (such as microcephaly, hypertelorism, low-set ears, prominent nose, short columella, cleft palate, micrognathia, and wide mouth).</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23476">
@@ -414677,7 +414914,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123538" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160919" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare functional neutrophil defect characterized by increased susceptibility to aggressive periodontitis in otherwise young, healthy individuals, due to impaired polymorphonuclear leukocyte chemotaxis toward bacterial formylpeptides. The periodontitis is rapidly progressive with progredient destruction of periodontal tissue and attachment loss.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23521">
@@ -414950,7 +415197,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123637" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161070" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare hereditary hemochromatosis characterized by mild to moderate late-onset iron overload with increased serum ferritin, normal or high transferrin saturation, and increased liver iron concentration. Associated laboratory findings are more pronounced in males than in females.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23544">
@@ -415592,7 +415849,7 @@
       </DisorderFlagList>
       <SynonymList count="2">
         <Synonym lang="en">DST-related epidermolysis bullosa simplex</Synonym>
-        <Synonym lang="en">EBS-AR BP230</Synonym>
+        <Synonym lang="en">EBS due to BP230 deficiency</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -415712,7 +415969,7 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
-        <Synonym lang="en">EBS-AR exophilin 5</Synonym>
+        <Synonym lang="en">EBS due to exophilin 5 deficiency</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -423444,7 +423701,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Dopamine beta-hydroxylase deficiency is an extremely rare genetic metabolic disorder characterized by autonomic dysregulation leading mainly to orthostatic hypotension.</Contents>
+              <Contents>A rare form of primary autonomic failure characterized by autonomic dysregulation leading mainly to orthostatic hypotension.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -428336,17 +428593,17 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="155137">
+        <ExternalReference id="187730">
           <Source>ICD-10</Source>
-          <Reference>L51.8</Reference>
+          <Reference>L51.2</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -430692,7 +430949,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by developmental delay and intellectual disability associated with brain malformations (including abnormal gyration patterns, ventriculomegaly, white matter abnormalities and hypoplasia of the corpus callosum and cerebellar hemispheres), facial dysmorphisms (including facial asymmetry, midface retraction, deep-set eyes, downslanting palpebral fissures, low-set ears, broad and depressed nasal bridge, short philtrum) and musculoskeletal abnormalities (including hemivertebrae, scoliosis or kyphosis, contractures, and joint laxity). Additional clinical manifestations include seizures, strabismus, vision loss, urogenital malformations, heart defects and short stature.</Contents>
+              <Contents>A rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by developmental delay, intellectual disability and mild to moderate facial dysmorphism in association with variable brain malformations (including abnormal gyration patterns, ventriculomegaly, white matter abnormalities, hypoplasia of the corpus callosum and cerebellar hemispheres), musculoskeletal abnormalities (including hemivertebrae, scoliosis or kyphosis, contractures, and joint laxity), ocular involvement (strabismus, hypermetropia and cortical visual impairment) and hypotonia. Additional clinical manifestations may include seizures, short stature urogenital malformations, heart defects and gastrointestinal malformations.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -437206,7 +437463,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123539" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160920" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare immune deficiency with skin involvement characterized by early infantile onset of a clinical tetrad comprising generalized severe seborrheic-like erythroderma, recurrent secondary bacterial or fungal infections (most commonly &lt;i&gt;Staphylococcus aureus&lt;/i&gt;, Candida, and gram-negative bacteria), persistent, profuse malabsorptive diarrhea, and failure to thrive or marked wasting. Associated systemic symptoms include fever, anemia, and weight loss. Further critical complications are impaired thermoregulation and severe fluid loss due to extensive exfoliation.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25866">
@@ -442461,7 +442728,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare non-malignant adnexal sweat gland neoplasm characterized by asymptomatic, skin-colored to pink papules or plaques with a highly variable appearance, most commonly in the head and neck area.</Contents>
+              <Contents>A rare non-malignant adnexal neoplasm that originates from the apocrine or eccrine sweat glands and is characterized histologically by cystic, papillary, and ductal invaginations into the dermis lined by double-layered outer cuboidal and luminal high columnar epithelium and connected to the epidermis. Dilated capillaries and a dense infiltrate of plasma cells are characteristic. Clinically, lesions are asymptomatic with a heterogeneous, non-distinctive appearance ranging from skin-colored to pink papules or plaques, occurring most commonly in the head and neck area.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -443658,8 +443925,7 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="3">
-        <Synonym lang="en">EBJ</Synonym>
+      <SynonymList count="2">
         <Synonym lang="en">Epidermolysis bullosa atrophicans</Synonym>
         <Synonym lang="en">JEB</Synonym>
       </SynonymList>
@@ -443969,7 +444235,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A clinically heterogeneous form of idiopathic inflammatory myopathy characterized by myositis, arthralgia, Raynaud phenomenon, mechanic hands, interstitial lung disease (ILD), and serum autoantibodies to aminoacyl transfer RNA synthetases (anti-ARS).</Contents>
+              <Contents>A rare idiopathic inflammatory myopathy (IIM) characterized principally by myositis, generally symmetrical arthritis and interstitial lung disease (ILD) in association with serum autoantibodies to aminoacyl-transfer RNA synthetases (anti-ARS). More variable features include arthralgia, Raynaud phenomenon, heliotrophic rash, distal esophageal dysmotility and mechanic's hands.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -453666,20 +453932,7 @@
       <DisorderGroup id="36540">
         <Name lang="en">Group of disorders</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="179633">
-          <Source>ICD-10</Source>
-          <Reference>Q43.1</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -455022,7 +455275,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Limb-mammary syndrome (LMS) is a rare disease belonging to the group of ectodermal dysplasias.</Contents>
+              <Contents>A rare, genetic, ectodermal dysplasia syndrome characterized by severe hand/foot anomalies, breast and/or nipple hypoplasia, and ectodermal dysplasia (principally teeth and nail anomalies). Cleft lip/palate may be variably present.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -455050,17 +455303,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="7">
-        <ExternalReference id="179645">
+        <ExternalReference id="187710">
           <Source>ICD-10</Source>
-          <Reference>Q82.2</Reference>
+          <Reference>Q82.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="10352">
@@ -461291,20 +461544,14 @@
       <OrphaCode>63269</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=63269</ExpertLink>
       <Name lang="en">Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis</Name>
-      <DisorderFlagList count="2">
-        <DisorderFlag id="459">
-          <Value>256</Value>
-          <Label>Deprecated entity</Label>
-        </DisorderFlag>
+      <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="3">
-        <Synonym lang="en">Ambiguous genitalia-disordered steroidogenesis Antley-Bixler-like syndrome</Synonym>
-        <Synonym lang="en">Antley-Bixler syndrome type 1</Synonym>
-        <Synonym lang="en">Antley-Bixler syndrome, POR-related</Synonym>
+      <SynonymList count="1">
+        <Synonym lang="en">Ambiguous genitalia-disordered steroidogenesis Antley-Bixler syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -461325,26 +461572,9 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="1">
-        <DisorderDisorderAssociation>
-          <TargetDisorder id="12654">
-            <OrphaCode>95699</OrphaCode>
-            <Name lang="en">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</Name>
-          </TargetDisorder>
-          <RootDisorder id="10819" cycle="true"/>
-          <DisorderDisorderAssociationType id="21471">
-            <Name lang="en">Moved to</Name>
-          </DisorderDisorderAssociationType>
-        </DisorderDisorderAssociation>
+      <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This disease has been moved to  Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10816">
@@ -461791,7 +462021,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare autoimmune bullous skin disease characterized by pruritus with or without polymorphic skin eruptions, affecting pregnant women typically during the second and third trimester. Skin eruptions may include erythematous papules and plaques, erythema multiforme-like or eczematous lesions, papulovesicles, and bullae, and typically affect the umbilicus, abdomen, and extremities.</Contents>
+              <Contents>A rare autoimmune bullous skin disease characterized by pruritus with or without polymorphic skin eruption, affecting pregnant women typically during the second and third trimester.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -463884,7 +464114,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>SUNCT syndrome (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) is a primary headache disorder characterized by unilateral trigeminal pain that occurs in association with ipsilateral cranial autonomic symptoms (conjunctival injection and tearing).</Contents>
+              <Contents>A rare primary headache disorder characterized by unilateral trigeminal pain that occurs in association with ipsilateral cranial autonomic symptoms (conjunctival injection and tearing).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -468764,7 +468994,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Seizures-intellectual disability due to hydroxylysinuria syndrome is characterised by hydroxylysinuria, myoclonic and motor seizures and intellectual deficit. It has been described in a brother and sister born to consanguineous parents and in one unrelated patient.</Contents>
+              <Contents>A rare inborn error of metabolism characterized by infantile onset of global developmental delay, severe intellectual disability, seizures, and movement disorder (including tremor, hyperkinesia, and myoclonus), associated with excessive excretion of hydroxylysine in urine. There have been no further descriptions in the literature since 1970.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -475735,10 +475965,11 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
+      <SynonymList count="5">
         <Synonym lang="en">EDS VIII</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome type 8</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome, periodontitis type</Synonym>
+        <Synonym lang="en">Periodontal EDS</Synonym>
         <Synonym lang="en">pEDS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -475949,9 +476180,10 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="2">
+      <SynonymList count="3">
         <Synonym lang="en">EDS V</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome type 5</Synonym>
+        <Synonym lang="en">X-linked EDS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -480276,7 +480508,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Ossification anomalies-psychomotor developmental delay syndrome is characterised by hypomineralisation of the cranial bones, thoracic dystrophy, hypotonia, and abnormal and slender long bones due to an alteration in remodelling during ossification.</Contents>
+              <Contents>A rare primary bone dysplasia characterized by global developmental delay, hypotonia, ossification anomalies of the cranial vault, abnormalities of the long bones due to defective remodeling, thoracic deformity, and progressive osteopenia. Dysmorphic craniofacial features include microcephaly, hypertelorism, narrow mouth, cleft palate, and micrognathia.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -485943,7 +486175,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Buerger disease, also known as thromboangiitis obliterans (TAO), is a rare inflammatory non-necrotizing vascular disease affecting the small- and medium-sized arteries and veins of the upper and lower extremities characterized by endarteritis and vaso-occlusion due to occlusive thrombus development. The development and progression of the disease is consistently associated with exposure to tobacco.</Contents>
+              <Contents>A rare inflammatory, non-necrotizing, non-atherosclerotic, occlusive vascular disease characterized by thrombosis and recanalization affecting small and medium sized arteries and veins of upper and lower extremities.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -486524,7 +486756,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Polymicrogyria (PMG) is a heterogenous group of cerebral cortical malformations characterized by excessive cortical folding and abnormal cortical layering that, depending on its topographic distribution, presents with variable combinations of neurological symptoms of varying severity such as epilepsy, developmental delay, intellectual disability, motor dysfunction (e.g. spasticity), and pseudobulbar palsy</Contents>
+              <Contents>A heterogenous group of cerebral cortical malformations characterized by excessive cortical folding and abnormal cortical layering that, depending on its topographic distribution, presents with variable combinations of neurological symptoms of varying severity such as epilepsy, developmental delay, intellectual disability, motor dysfunction (e.g. spasticity), and pseudobulbar palsy.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -488120,7 +488352,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Lymphedema - distichiasis is a rare syndromic lymphedema disorder characterized by lower-limb lymphedema and varying degrees of abnormal growth of eyelashes from the orifices of the Meibomian glands (distichiasis), with occasional associated manifestations.</Contents>
+              <Contents>A rare syndromic lymphedema disorder characterized by lower-limb lymphedema and varying degrees of abnormal growth of eyelashes from the orifices of the Meibomian glands (distichiasis), with occasional associated manifestations.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -490414,7 +490646,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179599">
+        <ExternalReference id="187736">
           <Source>ICD-10</Source>
           <Reference>Q79.6</Reference>
           <DisorderMappingRelation id="21534">
@@ -490423,8 +490655,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -490464,7 +490696,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179598">
+        <ExternalReference id="187735">
           <Source>ICD-10</Source>
           <Reference>Q79.6</Reference>
           <DisorderMappingRelation id="21534">
@@ -490473,8 +490705,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -490503,8 +490735,9 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
+      <SynonymList count="5">
         <Synonym lang="en">B3GALT6-related spEDS</Synonym>
+        <Synonym lang="en">B3GALT6-related spondylodysplastic EDS</Synonym>
         <Synonym lang="en">Beta3GalT6-deficient EDS</Synonym>
         <Synonym lang="en">Ehlers-Danlos syndrome progeroid type 2</Synonym>
         <Synonym lang="en">spEDS-B3GALT6</Synonym>
@@ -490527,7 +490760,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179597">
+        <ExternalReference id="187734">
           <Source>ICD-10</Source>
           <Reference>Q79.6</Reference>
           <DisorderMappingRelation id="21534">
@@ -490536,8 +490769,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -490579,7 +490812,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179601">
+        <ExternalReference id="187738">
           <Source>ICD-10</Source>
           <Reference>Q79.6</Reference>
           <DisorderMappingRelation id="21534">
@@ -490588,8 +490821,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -490642,7 +490875,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179600">
+        <ExternalReference id="187737">
           <Source>ICD-10</Source>
           <Reference>Q79.6</Reference>
           <DisorderMappingRelation id="21534">
@@ -490651,8 +490884,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -492776,7 +493009,7 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179608">
+        <ExternalReference id="187739">
           <Source>ICD-10</Source>
           <Reference>L88</Reference>
           <DisorderMappingRelation id="21534">
@@ -492785,8 +493018,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -494231,7 +494464,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179644">
+        <ExternalReference id="187709">
           <Source>ICD-10</Source>
           <Reference>Q68.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -494240,8 +494473,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="139311">
@@ -494281,7 +494514,7 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179611">
+        <ExternalReference id="187742">
           <Source>ICD-10</Source>
           <Reference>L88</Reference>
           <DisorderMappingRelation id="21534">
@@ -494290,8 +494523,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -494447,7 +494680,7 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179610">
+        <ExternalReference id="187741">
           <Source>ICD-10</Source>
           <Reference>L88</Reference>
           <DisorderMappingRelation id="21534">
@@ -494456,8 +494689,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -494495,7 +494728,7 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179609">
+        <ExternalReference id="187740">
           <Source>ICD-10</Source>
           <Reference>L88</Reference>
           <DisorderMappingRelation id="21534">
@@ -494504,8 +494737,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -498633,17 +498866,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179616">
+        <ExternalReference id="187743">
           <Source>ICD-10</Source>
           <Reference>L92.1</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21597">
-            <Name lang="en">Index term (The ORPHA code is listed in the ICD10 Index)</Name>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -498800,17 +499033,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179617">
+        <ExternalReference id="187744">
           <Source>ICD-10</Source>
           <Reference>L95.0</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21597">
-            <Name lang="en">Index term (The ORPHA code is listed in the ICD10 Index)</Name>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -499481,12 +499714,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="123569" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160985" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A group of rare congenital coronary artery malformations comprising abnormal number of coronary ostia, malposition of a coronary ostium, and stenosis or atresia of a coronary ostium. Patients may remain asymptomatic or present with variable signs and symptoms, depending on the nature and severity of the malformation, including failure to thrive, dyspnea, syncope, angina pectoris, ventricular tachycardia, and myocardial ischemia.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -502520,17 +502756,17 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179625">
+        <ExternalReference id="187745">
           <Source>ICD-10</Source>
-          <Reference>K76.8</Reference>
+          <Reference>K75.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -502797,17 +503033,17 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179626">
+        <ExternalReference id="187746">
           <Source>ICD-10</Source>
-          <Reference>K76.8</Reference>
+          <Reference>K75.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -502979,17 +503215,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179628">
+        <ExternalReference id="187748">
           <Source>ICD-10</Source>
-          <Reference>Q22</Reference>
+          <Reference>Q23.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="163329">
@@ -503252,7 +503488,7 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179629">
+        <ExternalReference id="187749">
           <Source>ICD-10</Source>
           <Reference>E27.4</Reference>
           <DisorderMappingRelation id="21534">
@@ -503261,14 +503497,24 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123619" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161052" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare type of familial hypoaldosteronism characterized by early infantile onset of vomiting, diarrhea, severe dehydration, and failure to thrive. Analysis of plasma electrolytes shows hyponatremia, hyperkalemia, and acidosis. Plasma renin activity is elevated, and aldosterone levels are low.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10525">
@@ -503317,7 +503563,7 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179630">
+        <ExternalReference id="187750">
           <Source>ICD-10</Source>
           <Reference>E27.4</Reference>
           <DisorderMappingRelation id="21534">
@@ -503326,14 +503572,24 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123618" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161051" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare form of familial hypoaldosteronism characterized by adult onset of subnormal plasma aldosterone with elevated plasma renin activity, hyperkalemia, metabolic acidosis, and hypotension. Signs and symptoms are typically mild, and affected individuals may be clinically asymptomatic and diagnosed only after biochemical screening.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10528">
@@ -507152,7 +507408,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179171">
+        <ExternalReference id="187747">
           <Source>ICD-10</Source>
           <Reference>K75.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -508297,7 +508553,7 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
-        <Synonym lang="en">DEB, pruriginosa</Synonym>
+        <Synonym lang="en">DEB pruriginosa</Synonym>
         <Synonym lang="en">DEB-Pr</Synonym>
         <Synonym lang="en">Pruriginous dystrophic epidermolysis bullosa</Synonym>
       </SynonymList>
@@ -508362,24 +508618,18 @@
     <Disorder id="11907">
       <OrphaCode>89842</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=89842</ExpertLink>
-      <Name lang="en">Recessive dystrophic epidermolysis bullosa, generalized intermediate</Name>
+      <Name lang="en">Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="10">
+      <SynonymList count="4">
         <Synonym lang="en">Autosomal recessive dystrophic epidermolysis bullosa generalisata mitis</Synonym>
-        <Synonym lang="en">Autosomal recessive dystrophic epidermolysis bullosa, generalized other</Synonym>
-        <Synonym lang="en">Generalized mitis RDEB</Synonym>
-        <Synonym lang="en">RDEB generalisata mitis</Synonym>
-        <Synonym lang="en">RDEB, generalized intermediate</Synonym>
+        <Synonym lang="en">Autosomal recessive dystrophic epidermolysis bullosa, non-Hallopeau-Siemens type</Synonym>
+        <Synonym lang="en">Generalized RDEB, intermediate form</Synonym>
         <Synonym lang="en">RDEB, non-Hallopeau-Siemens type</Synonym>
-        <Synonym lang="en">RDEB-O</Synonym>
-        <Synonym lang="en">RDEB-generalized other</Synonym>
-        <Synonym lang="en">Recessive dystrophic epidermolysis bullosa, non-Hallopeau-Siemens type</Synonym>
-        <Synonym lang="en">Recessive dystrophic epidermolysis bullosa-generalized other</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -508402,7 +508652,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11907" cycle="true"/>
+          <RootDisorder id="11906">
+            <OrphaCode>89841</OrphaCode>
+            <Name lang="en">OBSOLETE: Centripetalis recessive dystrophic epidermolysis bullosa</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="34574" lang="en">
@@ -508482,9 +508742,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=89841</ExpertLink>
       <Name lang="en">OBSOLETE: Centripetalis recessive dystrophic epidermolysis bullosa</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="461">
-          <Value>1024</Value>
-          <Label>Obsolete with resources</Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
@@ -508500,7 +508760,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11907">
+            <OrphaCode>89842</OrphaCode>
+            <Name lang="en">Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form</Name>
+          </TargetDisorder>
+          <RootDisorder id="11906" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="0">
       </SummaryInformationList>
@@ -508510,9 +508780,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=89840</ExpertLink>
       <Name lang="en">OBSOLETE: Junctional epidermolysis bullosa, non-Herlitz type</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="461">
-          <Value>1024</Value>
-          <Label>Obsolete with resources</Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
@@ -508526,7 +508796,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11428">
+            <OrphaCode>79402</OrphaCode>
+            <Name lang="en">Intermediate generalized junctional epidermolysis bullosa</Name>
+          </TargetDisorder>
+          <RootDisorder id="11905" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="0">
       </SummaryInformationList>
@@ -508536,9 +508816,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=89839</ExpertLink>
       <Name lang="en">OBSOLETE: Epidermolysis bullosa simplex superficialis</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="461">
-          <Value>1024</Value>
-          <Label>Obsolete with resources</Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
@@ -508552,7 +508832,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="641">
+            <OrphaCode>304</OrphaCode>
+            <Name lang="en">Epidermolysis bullosa simplex</Name>
+          </TargetDisorder>
+          <RootDisorder id="11904" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="0">
       </SummaryInformationList>
@@ -517843,18 +518133,15 @@
     <Disorder id="11903">
       <OrphaCode>89838</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=89838</ExpertLink>
-      <Name lang="en">Epidermolysis bullosa simplex, autosomal recessive K14</Name>
+      <Name lang="en">Autosomal recessive generalized epidermolysis bullosa simplex</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
-        <Synonym lang="en">EBS, autosomal recessive K14</Synonym>
-        <Synonym lang="en">EBS-AR KRT14</Synonym>
-        <Synonym lang="en">KRT14-related autosomal recessive EBS</Synonym>
-        <Synonym lang="en">KRT14-related autosomal recessive epidermolysis bullosa simplex</Synonym>
+      <SynonymList count="1">
+        <Synonym lang="en">Autosomal recessive generalized EBS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -519472,7 +519759,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123580" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160997" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic intellectual disability characterized by the association of intellectual disability with variable other anomalies in the absence of a well-characterized syndrome. Associated abnormalities may include facial dysmorphism, neurological signs and symptoms, behavioral problems, and abnormalities of various other organ systems.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12194">
@@ -520919,7 +521216,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179675">
+        <ExternalReference id="187733">
           <Source>ICD-10</Source>
           <Reference>E75.2</Reference>
           <DisorderMappingRelation id="21534">
@@ -520928,8 +521225,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -523474,7 +523771,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179674">
+        <ExternalReference id="187732">
           <Source>ICD-10</Source>
           <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -523483,8 +523780,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -535103,7 +535400,7 @@
     <Disorder id="11422">
       <OrphaCode>79396</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79396</ExpertLink>
-      <Name lang="en">Epidermolysis bullosa simplex, generalized severe</Name>
+      <Name lang="en">Autosomal dominant generalized epidermolysis bullosa simplex, severe form</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -535111,9 +535408,9 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
-        <Synonym lang="en">EBS, generalized severe</Synonym>
+        <Synonym lang="en">Autosomal dominant generalized EBS, severe form</Synonym>
+        <Synonym lang="en">Epidermolysis bullosa simplex herpetiformis</Synonym>
         <Synonym lang="en">Epidermolysis bullosa simplex, Dowling-Meara type</Synonym>
-        <Synonym lang="en">Epidermolysis bullosa simplex, herpetiformis</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -535183,7 +535480,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
+        <Synonym lang="en">EBS with mottled pigmentation</Synonym>
         <Synonym lang="en">EBS-MP</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -536169,19 +536467,17 @@
     <Disorder id="11425">
       <OrphaCode>79399</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79399</ExpertLink>
-      <Name lang="en">Epidermolysis bullosa simplex, generalized intermediate</Name>
+      <Name lang="en">Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="5">
-        <Synonym lang="en">EBS, generalized intermediate</Synonym>
+      <SynonymList count="3">
+        <Synonym lang="en">Autosomal dominant generalized EBS, intermediate form</Synonym>
         <Synonym lang="en">Epidermolysis bullosa simplex, Koebner type</Synonym>
         <Synonym lang="en">Epidermolysis bullosa simplex, Kbner type</Synonym>
-        <Synonym lang="en">Generalized EBS, non-Dowling-Meara type</Synonym>
-        <Synonym lang="en">Generalized epidermolysis bullosa simplex, non-Dowling-Meara type</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -536255,7 +536551,7 @@
     <Disorder id="11427">
       <OrphaCode>79401</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79401</ExpertLink>
-      <Name lang="en">PLEC-related epidermolysis bullosa simplex without extracutaneous involvement</Name>
+      <Name lang="en">PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -536263,7 +536559,7 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
-        <Synonym lang="en">PLEC-related EBS without extracutaneous involvement</Synonym>
+        <Synonym lang="en">PLEC-related intermediate EBS without extracutaneous involvement</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -536344,10 +536640,11 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="3">
+      <SynonymList count="4">
         <Synonym lang="en">EBS-loc</Synonym>
         <Synonym lang="en">Epidermolysis bullosa simplex of palms and soles</Synonym>
         <Synonym lang="en">Epidermolysis bullosa simplex, Weber-Cockayne type</Synonym>
+        <Synonym lang="en">Localized EBS</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -536410,15 +536707,16 @@
     <Disorder id="11429">
       <OrphaCode>79403</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79403</ExpertLink>
-      <Name lang="en">Junctional epidermolysis bullosa-pyloric atresia syndrome</Name>
+      <Name lang="en">Junctional epidermolysis bullosa with pyloric atresia</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="2">
+      <SynonymList count="3">
         <Synonym lang="en">Carmi syndrome</Synonym>
+        <Synonym lang="en">JEB with pyloric atresia</Synonym>
         <Synonym lang="en">JEB-PA</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -536482,7 +536780,7 @@
     <Disorder id="11428">
       <OrphaCode>79402</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79402</ExpertLink>
-      <Name lang="en">Junctional epidermolysis bullosa, generalized intermediate</Name>
+      <Name lang="en">Intermediate generalized junctional epidermolysis bullosa</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -536493,7 +536791,7 @@
         <Synonym lang="en">GABEB</Synonym>
         <Synonym lang="en">Generalized atrophic benign epidermolysis bullosa</Synonym>
         <Synonym lang="en">Generalized junctional epidermolysis bullosa, non-Herlitz type</Synonym>
-        <Synonym lang="en">JEB, generalized intermediate</Synonym>
+        <Synonym lang="en">Intermediate generalized JEB</Synonym>
         <Synonym lang="en">JEB-nH gen</Synonym>
         <Synonym lang="en">Junctional epidermolysis bullosa generalisata mitis</Synonym>
         <Synonym lang="en">Junctional epidermolysis bullosa, Disentis type</Synonym>
@@ -536530,7 +536828,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11428" cycle="true"/>
+          <RootDisorder id="11905">
+            <OrphaCode>89840</OrphaCode>
+            <Name lang="en">OBSOLETE: Junctional epidermolysis bullosa, non-Herlitz type</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="34972" lang="en">
@@ -536555,9 +536863,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="3">
-        <Synonym lang="en">EBJ-I</Synonym>
-        <Synonym lang="en">Inverse JEB</Synonym>
+      <SynonymList count="2">
+        <Synonym lang="en">JEB inversa</Synonym>
         <Synonym lang="en">JEB-I</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -536621,7 +536928,7 @@
     <Disorder id="11430">
       <OrphaCode>79404</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79404</ExpertLink>
-      <Name lang="en">Junctional epidermolysis bullosa, generalized severe</Name>
+      <Name lang="en">Severe generalized junctional epidermolysis bullosa</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -536630,11 +536937,11 @@
       </DisorderFlagList>
       <SynonymList count="6">
         <Synonym lang="en">Epidermolysis bullosa letalis</Synonym>
-        <Synonym lang="en">JEB, generalized severe</Synonym>
         <Synonym lang="en">JEB-H</Synonym>
         <Synonym lang="en">Junctional epidermolysis bullosa generalisata gravis</Synonym>
         <Synonym lang="en">Junctional epidermolysis bullosa, Herlitz type</Synonym>
         <Synonym lang="en">Junctional epidermolysis bullosa, Herlitz-Pearson type</Synonym>
+        <Synonym lang="en">Severe generalized JEB</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -536723,7 +537030,7 @@
         <DisorderDisorderAssociation>
           <TargetDisorder id="19201">
             <OrphaCode>231568</OrphaCode>
-            <Name lang="en">Generalized dominant dystrophic epidermolysis bullosa</Name>
+            <Name lang="en">Autosomal dominant generalized dystrophic epidermolysis bullosa</Name>
           </TargetDisorder>
           <RootDisorder id="11433" cycle="true"/>
           <DisorderDisorderAssociationType id="21471">
@@ -536795,17 +537102,16 @@
     <Disorder id="11435">
       <OrphaCode>79409</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79409</ExpertLink>
-      <Name lang="en">Recessive dystrophic epidermolysis bullosa inversa</Name>
+      <Name lang="en">Dystrophic epidermolysis bullosa inversa</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
-        <Synonym lang="en">Dystrophic epidermolysis bullosa inversa</Synonym>
-        <Synonym lang="en">Inverse RDEB</Synonym>
-        <Synonym lang="en">Inverse recessive dystrophic epidermolysis bullosa</Synonym>
+      <SynonymList count="3">
+        <Synonym lang="en">Autosomal recessive dystrophic epidermolysis bullosa inversa</Synonym>
+        <Synonym lang="en">RDEB inversa</Synonym>
         <Synonym lang="en">RDEB-I</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -536858,7 +537164,7 @@
     <Disorder id="11434">
       <OrphaCode>79408</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79408</ExpertLink>
-      <Name lang="en">Severe generalized recessive dystrophic epidermolysis bullosa</Name>
+      <Name lang="en">Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -536868,9 +537174,9 @@
       <SynonymList count="6">
         <Synonym lang="en">Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis</Synonym>
         <Synonym lang="en">Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type</Synonym>
+        <Synonym lang="en">Generalized RDEB, severe form</Synonym>
         <Synonym lang="en">RDEB generalisata gravis</Synonym>
         <Synonym lang="en">RDEB, Hallopeau-Siemens type</Synonym>
-        <Synonym lang="en">RDEB-sev gen</Synonym>
         <Synonym lang="en">Severe generalized RDEB</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -536923,7 +537229,7 @@
     <Disorder id="11437">
       <OrphaCode>79411</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79411</ExpertLink>
-      <Name lang="en">Transient bullous dermolysis of the newborn</Name>
+      <Name lang="en">Self-improving dystrophic epidermolysis bullosa</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -536931,8 +537237,8 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="2">
-        <Synonym lang="en">DEB, bullous dermolysis of the newborn</Synonym>
-        <Synonym lang="en">DEB-BDN</Synonym>
+        <Synonym lang="en">Self-improving DEB</Synonym>
+        <Synonym lang="en">Transient bullous dermolysis of the newborn</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -537006,7 +537312,7 @@
     <Disorder id="11436">
       <OrphaCode>79410</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79410</ExpertLink>
-      <Name lang="en">Pretibial dystrophic epidermolysis bullosa</Name>
+      <Name lang="en">Localized dystrophic epidermolysis bullosa, pretibial form</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -537015,7 +537321,7 @@
       </DisorderFlagList>
       <SynonymList count="2">
         <Synonym lang="en">DEB-Pt</Synonym>
-        <Synonym lang="en">Pretibial DEB</Synonym>
+        <Synonym lang="en">Localized DEB, pretibial form</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -547927,7 +548233,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>MEHMO syndrome is characterised by severe intellectual deficit, epilepsy, microcephaly, hypogenitalism, and obesity. Growth delay and diabetes are also present. To date, it has been described in seven boys, all of whom died within the first two years of life. The causative gene has been localised to the 21.1-22.13p region of the X chromosome and the syndrome appears to result from mitochondrial dysfunction.</Contents>
+              <Contents>A rare X-linked syndromic intellectual disability characterized by mild to profound intellectual disability, microcephaly, growth delay, and hypogenitalism. Obesity, early-onset diabetes and epilepsy are more variably present.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -553302,7 +553608,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179673">
+        <ExternalReference id="187731">
           <Source>ICD-10</Source>
           <Reference>G11.0</Reference>
           <DisorderMappingRelation id="21534">
@@ -553311,8 +553617,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -565020,7 +565326,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">EDS</Synonym>
       </SynonymList>
       <DisorderType id="21436">
         <Name lang="en">Clinical group</Name>
@@ -572733,7 +573040,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123532" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="160915" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare renal disease characterized by congenital unilateral or bilateral narrowing of the renal artery leading to severe arterial hypertension and progressive renal failure in the neonate. Manifestations include hypertensive encephalopathy and/or neurological signs and symptoms due to hyponatremia, polyuria, renal electrolyte loss, proteinuria, and hematuria.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12935">
@@ -574904,17 +575221,7 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="1">
-        <DisorderDisorderAssociation>
-          <TargetDisorder id="12654" cycle="true"/>
-          <RootDisorder id="10819">
-            <OrphaCode>63269</OrphaCode>
-            <Name lang="en">Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis</Name>
-          </RootDisorder>
-          <DisorderDisorderAssociationType id="21471">
-            <Name lang="en">Moved to</Name>
-          </DisorderDisorderAssociationType>
-        </DisorderDisorderAssociation>
+      <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="23870" lang="en">
@@ -579752,17 +580059,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="117905">
+        <ExternalReference id="187711">
           <Source>ICD-10</Source>
-          <Reference>Q93.5</Reference>
+          <Reference>Q87.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -587927,7 +588234,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Brachydactyly type A7 (Smorgasbord type) is a form of brachydactyly that presents with the characteristic features of brachydactyly type A2 (shortening of the middle phalanges of the index finger and, sometimes, of the little finger) and type D (shortening of the distal phalanx of the thumb) plus various additional features.</Contents>
+              <Contents>A rare dysostosis with brachydactyly characterized by variable combinations of features of brachydactyly types A2 (such as delta-shaped middle phalanx of the second finger or toe) and D (short, broad distal phalanx of the thumb) and other types of brachydactyly (symphalangism), as well as unique features (dislocatable thumbs, lateral deviation of second toes with elevation of first toes). There have been no further descriptions in the literature since 1989.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -589103,18 +589410,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="52010">
-          <Source>OMIM</Source>
-          <Reference>309580</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -592141,6 +592437,39 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29775">
+      <OrphaCode>596426</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596426</ExpertLink>
+      <Name lang="en">Syndromes of reduced sensitivity to thyroid hormone</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">RTH</Synonym>
+      </SynonymList>
+      <DisorderType id="21436">
+        <Name lang="en">Clinical group</Name>
+      </DisorderType>
+      <DisorderGroup id="36540">
+        <Name lang="en">Group of disorders</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12431">
       <OrphaCode>93598</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93598</ExpertLink>
@@ -592310,6 +592639,31 @@
       <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29762">
+      <OrphaCode>596008</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596008</ExpertLink>
+      <Name lang="en">Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21450">
+        <Name lang="en">Clinical subtype</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12419">
       <OrphaCode>93579</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93579</ExpertLink>
@@ -593335,6 +593689,33 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29776">
+      <OrphaCode>596448</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596448</ExpertLink>
+      <Name lang="en">IgG4-related systemic disease</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="en">IgG4-RD</Synonym>
+        <Synonym lang="en">IgG4-related disease</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12433">
       <OrphaCode>93600</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93600</ExpertLink>
@@ -595444,7 +595825,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123635" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161068" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare vascular anomaly characterized by a congenital anomalous connection between the inferior vena cava and the left atrium. Clinical manifestations depend on the presence and nature of additional cardiac defects and include cyanosis, dyspnea, failure to thrive, clubbing of fingers and toes, and potentially heart failure.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="14137">
@@ -605136,14 +605527,15 @@
     <Disorder id="13889">
       <OrphaCode>98872</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98872</ExpertLink>
-      <Name lang="en">Adult pure red cell aplasia</Name>
+      <Name lang="en">Primary acquired pure red cell aplasia</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Primary acquired PRCA</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -626006,17 +626398,18 @@
     <Disorder id="13438">
       <OrphaCode>98421</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98421</ExpertLink>
-      <Name lang="en">Red cell aplasia</Name>
+      <Name lang="en">Primary acquired red cell aplasia</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Primary autoimmune red cell aplasia</Synonym>
       </SynonymList>
-      <DisorderType id="36561">
-        <Name lang="en">Category</Name>
+      <DisorderType id="21436">
+        <Name lang="en">Clinical group</Name>
       </DisorderType>
       <DisorderGroup id="36540">
         <Name lang="en">Group of disorders</Name>
@@ -626110,7 +626503,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28857">
@@ -626260,7 +626660,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123617" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161050" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare acquired human prion disease characterized by progressive, invariably fatal neurodegeneration resulting from accidental transmission of CJD prions in the course of medical procedures or treatments (treatment with human pituitary growth hormone or gonadotrophin, human dura mater or corneal graft, exposure to contaminated neurosurgical instruments). Patients present rapidly progressive cognitive impairment, as well as myoclonus, visual or cerebellar problems, pyramidal or extrapyramidal features, and/or akinetic mutism. EEG examination may show characteristic generalized periodic sharp wave complexes. Neuropathologic analysis reveals spongiform change, neuronal loss and gliosis, and deposition of abnormal prion protein.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28853">
@@ -626359,7 +626769,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123594" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161011" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare acquired human prion disease characterized by a progressive, invariably fatal neuropsychiatric disorder resulting from transmission via consumption of products from prion-diseased cows or via blood transfusion from an affected individual. Patients typically present early psychiatric symptoms (such as depression, anxiety, apathy, withdrawal, and delusions), as well as persistent painful sensory symptoms, ataxia, myoclonus, chorea, or dystonia, and dementia. Brain MRI often shows bilateral FLAIR hyperintensities involving the pulvinar thalamic nuclei. Neuropathological examination reveals spongiform change and extensive deposition of abnormal prion protein with florid plaques throughout the cerebrum and cerebellum.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28854">
